KR20190040791A - 4 Ring-fused N-heterocycles having luminescent properties and Preparation method thereof - Google Patents
4 Ring-fused N-heterocycles having luminescent properties and Preparation method thereofInfo
- Publication number
- KR20190040791A KR20190040791A KR1020170131542A KR20170131542A KR20190040791A KR 20190040791 A KR20190040791 A KR 20190040791A KR 1020170131542 A KR1020170131542 A KR 1020170131542A KR 20170131542 A KR20170131542 A KR 20170131542A KR 20190040791 A KR20190040791 A KR 20190040791A
- Authority
- KR
- South Korea
- Prior art keywords
- alkyl
- ethyl
- carboxylate
- heteroaryl
- branched
- Prior art date
Links
- SRTWBLXLXNMDEI-JCMHNJIXSA-N CCOC(c1c(-c(cccc2)c2/C2=C/c(cc3)ccc3F)[n]2c2c1cccc2)=O Chemical compound CCOC(c1c(-c(cccc2)c2/C2=C/c(cc3)ccc3F)[n]2c2c1cccc2)=O SRTWBLXLXNMDEI-JCMHNJIXSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- H01L51/0071—
-
- H01L51/50—
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
- H10K85/657—Polycyclic condensed heteroaromatic hydrocarbons
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1003—Carbocyclic compounds
- C09K2211/1011—Condensed systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1029—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Physics & Mathematics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Optics & Photonics (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Description
본 발명은 발광 특성을 가지는 4환 접합 N-헤테로고리 화합물 및 이의 제조방법에 관한 것이다.The present invention relates to a 4-ring junction N-heterocyclic compound having luminescent properties and a method for producing the same.
다중 접합 N-헤테로고리 화합물은 생리 활성이 뛰어나 약 후보물질로서 주목받고 있으며, 유기발광 다이오드의 정공 수송재(Hole Transporting Materials, HTM)로 사용되는 등 전자 물질에서도 중요한 근간이 되는 물질로서 각광받고 있다[a) J. Org. Chem. 2001, 66, 412, b) J. Med. Chem. 1995, 38, 669].The multi-junction N-heterocyclic compound has attracted attention as a candidate candidate for its excellent physiological activity and is widely used as a hole transporting material (HTM) of an organic light emitting diode [a) J. Org. Chem. 2001, 66, 412, b) J. Med. Chem. 1995, 38, 669].
최근에는 아자코라누렌(azacorannulene)이나 아자풀러렌(azafullerene)과 같이 내부에 질소 원자가 포함된 접합 방향족 고리화합물들이 에너지 전환 활용에서 전자적, 광학적으로 흥미로운 특성을 보이는 것이 발견되었다. Recently, conjugated aromatic ring compounds containing nitrogen atoms inside, such as azacorannulene and azafullerene, have been found to exhibit electronically and optically interesting properties in energy transfer applications.
이에, 다중 접합 N-헤테로고리 화합물을 합성하기 위한 다양한 방법들이 고안되었다. 이상적인 방법은 평범한 출발물질로부터 입체 특이적, 치환기 특이적 그리고 위치 특이적인 반응을 성공시키는 것이다. 비고리 출발물질로부터 원자-경제적으로 고리화 유기 물질을 만들 수 있는 방법들에 대한 다양한 연구가 요구되고 있다[a) Nat. Commun. 2015, 6, 8215, b) Angew. Chem. Int. Ed. 2010, 49, 6764; Angew. Chem. 2010, 122, 6916].Accordingly, various methods for synthesizing multi-junction N-heterocyclic compounds have been devised. The ideal method is to achieve stereospecific, substituent-specific, and site-specific reactions from common starting materials. There is a need for a variety of studies on methods to make atomic-economically cyclic organic materials from acyclic starting materials [a) Nat. Commun. 2015, 6, 8215, b) Angew. Chem. Int. Ed. 2010, 49, 6764; Angew. Chem. 2010, 122, 6916].
본 발명이 해결하고자 하는 첫 번째 과제는 발광 특성을 가지는 신규한 4환 접합 N-헤테로고리 화합물을 제공하는 것이다. The first problem to be solved by the present invention is to provide a novel 4-ring junction N-heterocyclic compound having a light emitting property.
본 발명이 해결하고자 하는 두 번째 과제는 상기 신규한 4환 접합 N-헤테로고리 화합물의 제조방법을 제공하는 것이다. A second object of the present invention is to provide a process for preparing the novel 4-ring junction N-heterocyclic compound.
상기한 과제를 달성하기 위하여 본 발명은 하기 화학식 1로 표시되는 화합물을 제공한다:In order to accomplish the above object, the present invention provides a compound represented by the following formula 1:
[화학식 1][Chemical Formula 1]
식 중에서,In the formula,
는 단일 또는 이중결합이고, Is a single or double bond,
A는 질소 원자를 포함하는, 5-6원 헤테로시클릭 또는 5-6원 헤테로아릴이고, A is a 5-6 membered heterocyclic or 5-6 membered heteroaryl containing a nitrogen atom,
R1은 수소, 직쇄형 또는 분지형 C1 - 6알킬 및 CO2Ra 중에서 선택되고,R 1 is hydrogen, straight or branched C 1 - 6 alkyl and is selected from CO 2 R a,
R2, R3, R4, R5 및 R6은 서로 동일하거나 또는 상이하고, 각각 독립적으로 수소, 할로, 직쇄형 또는 분지형 C1 - 6알킬, CO2Ra, C1 - 6알킬옥시, 트리할로메틸, 페닐 및 벤질 중에서 선택되고, R 2, R 3, R 4 , R 5 and R 6 are the same or different and each is independently hydrogen, halo, straight or branched C 1 to each other - 6 alkyl, CO 2 R a, C 1 - 6 alkyl Oxy, trihalomethyl, phenyl and benzyl,
R7은 직쇄형 또는 분지형 C1 - 6알킬, C3 - 7시클로알킬, 아릴, 헤테로아릴, 아릴C1-6알킬 및 헤테로아릴C1 - 6알킬 중에서 선택되고; 상기 아릴 또는 아릴C1 - 6알킬의 아릴은 페닐 또는 나프틸이며; 상기 헤테로아릴 또는 헤테로아릴C1 - 6알킬의 헤테로아릴은 N, O 및 S 중에서 선택되는 1 내지 2개의 이종원자를 가지는 5-6원 헤테로아릴, 1H-인돌릴 또는 1H-퀴놀리닐이며; 상기 아릴, 헤테로아릴, 아릴C1 - 6알킬 및 헤테로아릴C1- 6알킬은 각각 독립적으로 비치환되거나 또는 할로, 직쇄형 또는 분지형 C1-6알킬, C1 - 6알킬옥시, 트리할로메틸, -COOH, -CHO, -COORb, 페닐 및 벤질 중에서 선택되는 1 내지 3개의 치환기로 치환될 수 있고,R 7 is straight or branched C 1 - 6 alkyl is selected from 6-alkyl, C 3 - - 7 cycloalkyl, aryl, heteroaryl, aryl C 1-6 alkyl and heteroaryl C 1; And the aryl or aryl C 1 - 6 alkyl, aryl is phenyl or naphthyl; Wherein the heteroaryl or heteroaryl C 1 - 6 alkyl heteroaryl is N, O, and 5-6 membered having from 1 to 2 heteroatoms selected from S-heteroaryl, 1H- indolyl or quinolinyl 1H- and; Wherein the aryl, heteroaryl, aryl C 1 - 6 alkyl and heteroaryl C 1- 6 alkyl, each independently unsubstituted or substituted by halo, straight or branched C 1-6 alkyl, C 1 - 6 alkyloxy, trihalomethyl Romero naphthyl, may be optionally substituted by -COOH, -CHO, -COOR b, phenyl, and 1 to 3 substituents selected from benzyl,
Ra 및 Rb는 서로 동일하거나 또는 상이하고, 각각 독립적으로 직쇄형 또는 분지형 C1 - 6알킬이다.R a and R b are the same or different and each is independently a straight or branched C 1 to each other - a 6 alkyl.
본 발명에 있어서, 상기 화학식 1의 화합물은 하기 화학식 2 또는 화학식 3으로 표시되는 것일 수 있다.In the present invention, the compound of formula (1) may be represented by the following formula (2) or (3).
[화학식 2](2)
[화학식 3](3)
식 중에서,In the formula,
R1, R2, R3, R4, R5 및 R6은 앞에서 제시한 바와 같으며, R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are as previously indicated,
R8은 직쇄형 또는 분지형 C1 - 6알킬, C3 - 7시클로알킬, 아릴 및 헤테로아릴 중에서 선택되고, 상기 아릴은 페닐 또는 나프틸이며; 상기 헤테로아릴은 N, O 및 S 중에서 선택되는 1 내지 2개의 이종원자를 가지는 5-6원 헤테로아릴, 1H-인돌릴 또는 1H-퀴놀리닐이고, 상기 아릴 및 헤테로아릴은 각각 독립적으로 비치환되거나 또는 할로, 직쇄형 또는 분지형 C1 - 6알킬, C1 - 6알킬옥시, 트리할로메틸, -COOH, -CHO, -COORb, 페닐 및 벤질 중에서 선택되는 1 내지 3개의 치환기로 치환될 수 있고,R 8 is straight or branched C 1 - 6 alkyl, C 3 - 7 is selected from cycloalkyl, aryl, and heteroaryl, wherein the aryl is phenyl or naphthyl; Wherein said heteroaryl is 5-6 membered heteroaryl, 1H-indolyl or lH-quinolinyl having 1-2 heteroatoms selected from N, O and S, said aryl and heteroaryl being each independently unsubstituted or substituted or halo, straight or branched C 1 - 6 alkyl, C 1 - 6 alkyl optionally substituted by oxy, methyl, -COOH, -CHO, -COOR b, phenyl and benzyl 1 to 3 substituents selected from trihaloalkyl Can,
Rb는 직쇄형 또는 분지형 C1 - 6알킬이다.R b is a straight or branched C 1 - 6 is alkyl.
본 발명에 의하면, 상기 화학식 1로 표시되는 화합물은 R1이 CO2Et인 것일 수 있다.According to the present invention, the compound represented by Formula 1 may be that wherein R 1 is CO 2 Et.
본 발명에 의하면, 상기 화학식 2 또는 화학식 3로 표시되는 화합물은According to the present invention, the compound represented by Formula 2 or Formula 3
R1은 CO2Et이고,R 1 is CO 2 Et,
R8은 직쇄형 또는 분지형 C1 - 6알킬, 아릴 및 헤테로아릴 중에서 선택되고, 상기 아릴은 페닐 또는 나프틸이며; 상기 헤테로아릴은 O 및 S 중에서 선택되는 1 내지 2개의 이종원자를 가지는 5-6원 헤테로아릴이고; 상기 아릴 및 헤테로아릴은 각각 독립적으로 비치환되거나 또는 할로, 직쇄형 또는 분지형 C1 - 6알킬, C1 - 6알킬옥시, 트리할로메틸, -COOH, -CHO 및 -COORb 중에서 선택되는 1 내지 3개의 치환기로 치환될 수 있고,R 8 is straight or branched C 1 - 6 is selected from alkyl, aryl and heteroaryl, wherein the aryl is phenyl or naphthyl; Wherein said heteroaryl is 5-6 membered heteroaryl having 1 to 2 heteroatoms selected from O and S; Wherein aryl and heteroaryl are each independently unsubstituted or substituted by halo, straight or branched C 1 - 6 is alkyloxy, selected from methyl, -COOH, -CHO and -COOR b trihaloalkyl - 6 alkyl, C 1 Which may be substituted with 1 to 3 substituents,
Rb는 직쇄형 또는 분지형 C1 - 6알킬인 것일 수 있다.R b is a straight or branched C 1 - 6 alkyl which may be one.
본 발명에 있어서, 상기 화학식 1의 화합물은 에틸 (Z)-6-벤질리덴-6H-이소인돌로[2,1-a]인돌-11-카복실레이트;In the present invention, the compound of Formula 1 is ethyl (Z) -6-benzylidene-6H-isoindolo [2,1-a] indole-11-carboxylate;
에틸 (Z)-6-(4-메틸벤질리덴)-6H-이소인돌로[2,1-a]인돌-11-카복실레이트;Ethyl (Z) -6- (4-methylbenzylidene) -6H-isoindolo [2,1-a] indole-11-carboxylate;
에틸 (Z)-6-(4-(메톡시카보닐)벤질리덴)-6H-이소인돌로[2,1-a]인돌-11-카복실레이트;Ethyl (Z) -6- (4- (methoxycarbonyl) benzylidene) -6H-isoindolo [2,1-a] indole-11-carboxylate;
에틸 (Z)-6-(4-포밀벤질리덴)-6H-이소인돌로[2,1-a]인돌-11-카복실레이트;Ethyl (Z) -6- (4-formylbenzylidene) -6H-isoindolo [2,1-a] indole-11-carboxylate;
에틸 (Z)-6-(4-(트리플루오로메틸)벤질리덴)-6H-이소인돌로[2,1-a]인돌-11-카복실레이트;Ethyl (Z) -6- (4- (trifluoromethyl) benzylidene) -6H-isoindolo [2,1-a] indole-11-carboxylate;
에틸 (Z)-6-(4-플루오로벤질리덴)-6H-이소인돌로[2,1-a]인돌-11-카복실레이트; Ethyl (Z) -6- (4-fluorobenzylidene) -6H-isoindolo [2,1-a] indole-11-carboxylate;
에틸 (Z)-6-(2-메틸벤질리덴)-6H-이소인돌로[2,1-a]인돌-11-카복실레이트;Ethyl (Z) -6- (2-methylbenzylidene) -6H-isoindolo [2,1-a] indole-11-carboxylate;
에틸 (Z)-6-(3-메톡시벤질리덴)-6H-이소인돌로[2,1-a]인돌-11-카복실레이트;Ethyl (Z) -6- (3-methoxybenzylidene) -6H-isoindolo [2,1-a] indole-11-carboxylate;
에틸 (Z)-6-(3-클로로벤질리덴)-6H-이소인돌로[2,1-a]인돌-11-카복실레이트;Ethyl (Z) -6- (3-chlorobenzylidene) -6H-isoindolo [2,1-a] indole-11-carboxylate;
에틸 (Z)-6-(3-클로로벤질리덴)-6H-이소인돌로[2,1-a]인돌-11-카복실레이트;Ethyl (Z) -6- (3-chlorobenzylidene) -6H-isoindolo [2,1-a] indole-11-carboxylate;
에틸 (Z)-6-(티오펜-2-일메틸렌)-6H-이소인돌로[2,1-a]인돌-11-카복실레이트; Ethyl (Z) -6- (thiophen-2-ylmethylene) -6H-isoindolo [2,1-a] indole-11-carboxylate;
에틸 (Z)-6-(나프탈렌-2-일메틸렌)-6H-이소인돌로[2,1-a]인돌-11-카복실레이트;Ethyl (Z) -6- (naphthalene-2-ylmethylene) -6H-isoindolo [2,1-a] indole-11-carboxylate;
에틸 (Z)-6-벤질리덴-2-메톡시-6H-이소인돌로[2,1-a]인돌-11-카복실레이트;Ethyl (Z) -6-benzylidene-2-methoxy-6H-isoindolo [2,1-a] indole-11-carboxylate;
에틸 (Z)-6-벤질리덴-2-(트리플루오로메틸)-6H-이소인돌로[2,1-a]인돌-11-카복실레이트;Ethyl (Z) -6-benzylidene-2- (trifluoromethyl) -6H-isoindolo [2,1-a] indole-11-carboxylate;
에틸 (Z)-6-벤질리덴-8-메톡시-6H-이소인돌로[2,1-a]인돌-11-카복실레이트;Ethyl (Z) -6-benzylidene-8-methoxy-6H-isoindolo [2,1-a] indole-11-carboxylate;
에틸 (Z)-6-벤질리덴-8-브로모-6H-이소인돌로[2,1-a]인돌-11-카복실레이트;Ethyl (Z) -6-benzylidene-8-bromo-6H-isoindolo [2,1-a] indole-11-carboxylate;
에틸 5-페닐인돌로[2,1-a]이소퀴놀린-12-카복실레이트;Ethyl 5-phenylindolo [2,1-a] isoquinoline-12-carboxylate;
에틸 5-(p-톨릴)인돌로[2,1-a]이소퀴놀린-12-카복실레이트;Ethyl 5- (p-tolyl) indolo [2,1-a] isoquinoline-12-carboxylate;
에틸 5-(4-(메톡시카보닐)페닐)인돌로[2,1-a]이소퀴놀린-12-카복실레이트;Ethyl 5- (4- (methoxycarbonyl) phenyl) indolo [2,1-a] isoquinoline-12-carboxylate;
에틸 5-(4-포밀페닐)인돌로[2,1-a]이소퀴놀린-12-카복실레이트;Ethyl 5- (4-formylphenyl) indolo [2,1-a] isoquinoline-12-carboxylate;
에틸 5-(4-(트리플루오로메틸)페닐)인돌로[2,1-a]이소퀴놀린-12-카복실레이트;Ethyl 5- (4- (trifluoromethyl) phenyl) indolo [2,1-a] isoquinoline-12-carboxylate;
에틸 5-(4-플루오로페닐)인돌로[2,1-a]이소퀴놀린-12-카복실레이트;Ethyl 5- (4-fluorophenyl) indolo [2,1-a] isoquinoline-12-carboxylate;
에틸 5-(o-톨릴)인돌로[2,1-a]이소퀴놀린-12-카복실레이트;Ethyl 5- (o-tolyl) indolo [2,1-a] isoquinoline-12-carboxylate;
에틸 5-(3-메톡시페닐)인돌로[2,1-a]이소퀴놀린-12-카복실레이트;Ethyl 5- (3-methoxyphenyl) indolo [2,1-a] isoquinoline-12-carboxylate;
에틸 5-(3-클로로페닐)인돌로[2,1-a]이소퀴놀린-12-카복실레이트;Ethyl 5- (3-chlorophenyl) indolo [2,1-a] isoquinoline-12-carboxylate;
에틸 5-헥실인돌로[2,1-a]이소퀴놀린-12-카복실레이트;Ethyl 5-hexylindolo [2,1-a] isoquinoline-12-carboxylate;
에틸 5-(티오펜-2-yl)인돌로[2,1-a]이소퀴놀린-12-카복실레이트;Ethyl 5- (thiophen-2-yl) indolo [2,1-a] isoquinoline-12-carboxylate;
에틸 5-(나프탈렌-2-일)인돌로[2,1-a]이소퀴놀린-12-카복실레이트;Ethyl 5- (naphthalen-2-yl) indolo [2,1-a] isoquinoline-12-carboxylate;
에틸 10-메톡시-5-페닐인돌로[2,1-a]이소퀴놀린-12-카복실레이트;Ethyl 10-methoxy-5-phenylindolo [2,1-a] isoquinoline-12-carboxylate;
에틸 5-페닐-10-(트리플루오로메틸)인돌로[2,1-a]이소퀴놀린-12-카복실레이트;Ethyl 5-phenyl-10- (trifluoromethyl) indolo [2,1-a] isoquinoline-12-carboxylate;
에틸 3-메톡시-5-페닐인돌로[2,1-a]이소퀴놀린-12-카복실레이트; 및Ethyl 3-methoxy-5-phenylindolo [2,1-a] isoquinoline-12-carboxylate; And
에틸 3-브로모-5-페닐인돌로[2,1-a]이소퀴놀린-12-카복실레이트;로 이루어진 군 중에서 선택되는 것일 수 있다. Ethyl 3-bromo-5-phenylindolo [2,1-a] isoquinoline-12-carboxylate.
본 발명은 하기 화학식 3의 화합물을 전이금속 촉매하에서 환류시켜 분자 내 고리결합을 형성시키는 것을 포함하는, 상기 화학식 1로 표시되는 화합물의 제조방법을 제공한다:The present invention provides a process for preparing a compound represented by the formula (1), which comprises refluxing a compound of the formula (3) in the presence of a transition metal catalyst to form an intramolecular ring bond:
[화학식 3] (3)
식 중에서, R1, R2, R3, R4, R5 및 R6은 화학식 2 또는 화학식 3에서 제시한 바와 같다.In the formula, R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are as shown in the formula (2) or (3).
본 발명의 상기 제조방법에서 상기 전이금속 촉매는 Pd(OAc)2, PtCl4 및 AuCl3 중에서 선택되는 것일 수 있다. In the above production method of the present invention, the transition metal catalyst may be selected from Pd (OAc) 2 , PtCl 4 and AuCl 3 .
상기 전이금속 촉매가 Pd(OAc)2이면, α-첨가반응(5-exo-dig 고리화)이 형성되어 상기 화학식 2로 표시되는 화합물이 형성되는 것일 수 있다.If the transition metal catalyst is Pd (OAc) 2 , an α-addition reaction (5-exo-dig cyclization) may be formed to form a compound represented by Formula 2.
상기 전이금속 촉매가 PtCl4 또는 AuCl3이면, β-첨가반응(6-endo-dig 고리화)이 형성되어 상기 화학식 3으로 표시되는 화합물이 형성되는 것일 수 있다.If the transition metal catalyst is PtCl 4 or AuCl 3 , a β-addition reaction (6-endo-dig cyclization) may be formed to form the compound represented by Formula 3.
본 발명에 의하면, 상기 전이금속 촉매는 2 내지 20 mol%로 첨가되는 것일 수 있다.According to the present invention, the transition metal catalyst may be added in an amount of 2 to 20 mol%.
본 발명은 비고리 출발물질로부터 원자-경제적으로 고리화 유기물질인 다중 접합 N-헤테로고리 화합물을 합성할 수 있다. 본 발명에 따른 다중 접합 N-헤테로고리 화합물은 발광 특성을 나타낼 수 있으므로 발광 특성을 나타내는 화합물이 필요한 분야, 예를 들어 염료, DNA 염색, 제초제, OLED, OPV, 바이오센서, 세포이미징 프로브 등의 소재로 적용이 가능하다. The present invention is capable of synthesizing multi-junction N-heterocyclic compounds that are atomically-economically cyclic organic materials from an acyclic starting material. The multi-junction N-heterocyclic compound according to the present invention can exhibit luminescent characteristics, and thus can be used in a field requiring a compound exhibiting luminescent properties, for example, a dye, a DNA dye, a herbicide, an OLED, an OPV, a biosensor, Can be applied.
이하, 본 발명을 보다 상세하게 설명한다. Hereinafter, the present invention will be described in more detail.
본 발명은 하기 화학식 1로 표시되는 화합물을 제공한다:The present invention provides a compound represented by the following formula (1): < EMI ID =
[화학식 1][Chemical Formula 1]
식 중에서,In the formula,
는 단일 또는 이중결합이고, Is a single or double bond,
A는 질소 원자를 포함하는, 5-6원 헤테로시클릭 또는 5-6원 헤테로아릴이고, A is a 5-6 membered heterocyclic or 5-6 membered heteroaryl containing a nitrogen atom,
R1은 수소, 직쇄형 또는 분지형 C1 - 6알킬 및 CO2Ra 중에서 선택되고,R 1 is hydrogen, straight or branched C 1 - 6 alkyl and is selected from CO 2 R a,
R2, R3, R4, R5 및 R6은 서로 동일하거나 또는 상이하고, 각각 독립적으로 수소, 할로, 직쇄형 또는 분지형 C1 - 6알킬, CO2Ra, C1 - 6알킬옥시, 트리할로메틸, 페닐 및 벤질 중에서 선택되고, R 2, R 3, R 4 , R 5 and R 6 are the same or different and each is independently hydrogen, halo, straight or branched C 1 to each other - 6 alkyl, CO 2 R a, C 1 - 6 alkyl Oxy, trihalomethyl, phenyl and benzyl,
R7은 직쇄형 또는 분지형 C1 - 6알킬, C3 - 7시클로알킬, 아릴, 헤테로아릴, 아릴C1-6알킬 및 헤테로아릴C1 - 6알킬 중에서 선택되고; 상기 아릴 또는 아릴C1 - 6알킬의 아릴은 페닐 또는 나프틸이며; 상기 헤테로아릴 또는 헤테로아릴C1 - 6알킬의 헤테로아릴은 N, O 및 S 중에서 선택되는 1 내지 2개의 이종원자를 가지는 5-6원 헤테로아릴, 1H-인돌릴 또는 1H-퀴놀리닐이며; 상기 아릴, 헤테로아릴, 아릴C1 - 6알킬 및 헤테로아릴C1- 6알킬은 각각 독립적으로 비치환되거나 또는 할로, 직쇄형 또는 분지형 C1-6알킬, C1 - 6알킬옥시, 트리할로메틸, -COOH, -CHO, -COORb, 페닐 및 벤질 중에서 선택되는 1 내지 3개의 치환기로 치환될 수 있고,R 7 is straight or branched C 1 - 6 alkyl is selected from 6-alkyl, C 3 - - 7 cycloalkyl, aryl, heteroaryl, aryl C 1-6 alkyl and heteroaryl C 1; And the aryl or aryl C 1 - 6 alkyl, aryl is phenyl or naphthyl; Wherein the heteroaryl or heteroaryl C 1 - 6 alkyl heteroaryl is N, O, and 5-6 membered having from 1 to 2 heteroatoms selected from S-heteroaryl, 1H- indolyl or quinolinyl 1H- and; Wherein the aryl, heteroaryl, aryl C 1 - 6 alkyl and heteroaryl C 1- 6 alkyl, each independently unsubstituted or substituted by halo, straight or branched C 1-6 alkyl, C 1 - 6 alkyloxy, trihalomethyl Romero naphthyl, may be optionally substituted by -COOH, -CHO, -COOR b, phenyl, and 1 to 3 substituents selected from benzyl,
Ra 및 Rb는 서로 동일하거나 또는 상이하고, 각각 독립적으로 직쇄형 또는 분지형 C1 - 6알킬이다.R a and R b are the same or different and each is independently a straight or branched C 1 to each other - a 6 alkyl.
본 발명에 있어서, 상기 직쇄형 또는 분지형 C1 - 6알킬은 메틸, 에틸, n-프로필, 이소프로필, n-부틸, 이소부틸, tert-부틸, n-펜틸, 이소펜틸, n-헥실 및 이소헥실 중에서 선택되는 것일 수 있으며, 이에 한정되는 것은 아니다. In the present invention, the straight-chain or branched C 1 - 6 alkyl is methyl, ethyl, n- propyl, isopropyl, n- butyl, isobutyl, tert- butyl, n- pentyl, isopentyl, n- hexyl, and Isohexyl, and isohexyl, but is not limited thereto.
본 발명에 있어서, 상기 화학식 1의 화합물은 하기 화학식 2 또는 화학식 3으로 표시되는 화합물일 수 있다.In the present invention, the compound of Formula 1 may be a compound of Formula 2 or Formula 3.
[화학식 2](2)
[화학식 3](3)
식 중에서,In the formula,
R1, R2, R3, R4, R5 및 R6은 상기 화학식 1에서 제시한 바와 같으며, R 1 , R 2 , R 3 , R 4 , R 5, and R 6 are as shown in Formula 1,
R8은 직쇄형 또는 분지형 C1 - 6알킬, C3 - 7시클로알킬, 아릴 및 헤테로아릴 중에서 선택되고, 상기 아릴은 페닐 또는 나프틸이며; 상기 헤테로아릴은 N, O 및 S 중에서 선택되는 1 내지 2개의 이종원자를 가지는 5-6원 헤테로아릴, 1H-인돌릴 또는 1H-퀴놀리닐이고, 상기 아릴 및 헤테로아릴은 각각 독립적으로 비치환되거나 또는 할로, 직쇄형 또는 분지형 C1 - 6알킬, C1 - 6알킬옥시, 트리할로메틸, -COOH, -CHO, -COORb, 페닐 및 벤질 중에서 선택되는 1 내지 3개의 치환기로 치환될 수 있고,R 8 is straight or branched C 1 - 6 alkyl, C 3 - 7 is selected from cycloalkyl, aryl, and heteroaryl, wherein the aryl is phenyl or naphthyl; Wherein said heteroaryl is 5-6 membered heteroaryl, 1H-indolyl or lH-quinolinyl having 1-2 heteroatoms selected from N, O and S, said aryl and heteroaryl being each independently unsubstituted or substituted or halo, straight or branched C 1 - 6 alkyl, C 1 - 6 alkyl optionally substituted by oxy, methyl, -COOH, -CHO, -COOR b, phenyl and benzyl 1 to 3 substituents selected from trihaloalkyl Can,
Rb는 직쇄형 또는 분지형 C1 - 6알킬이다.R b is a straight or branched C 1 - 6 is alkyl.
본 발명에 의하면, 바람직한 상기 화학식 1로 표시되는 화합물은 R1이 CO2Et인 것일 수 있다.According to the present invention, preferred compounds represented by the above formula (1) are those wherein R 1 is CO 2 Et.
본 발명에 의하면, 바람직한 상기 화학식 1로 표시되는 화합물은 화학식 2 또는 화학식 3로 표시되는 화합물일 수 있고, 보다 바람직하게는 R1은 CO2Et이고; R8은 직쇄형 또는 분지형 C1 - 6알킬, 아릴 및 헤테로아릴 중에서 선택되고, 상기 아릴은 페닐 또는 나프틸이며; 상기 헤테로아릴은 O 및 S 중에서 선택되는 1 내지 2개의 이종원자를 가지는 5-6원 헤테로아릴이고; 상기 아릴 및 헤테로아릴은 각각 독립적으로 비치환되거나 또는 할로, 직쇄형 또는 분지형 C1 - 6알킬, C1 - 6알킬옥시, 트리할로메틸, -COOH, -CHO 및 -COORb 중에서 선택되는 1 내지 3개의 치환기로 치환될 수 있고,According to the present invention, preferred compounds represented by the above formula (1) may be compounds represented by formula (2) or (3), more preferably R 1 is CO 2 Et; R 8 is straight or branched C 1 - 6 is selected from alkyl, aryl and heteroaryl, wherein the aryl is phenyl or naphthyl; Wherein said heteroaryl is 5-6 membered heteroaryl having 1 to 2 heteroatoms selected from O and S; Wherein aryl and heteroaryl are each independently unsubstituted or substituted by halo, straight or branched C 1 - 6 is alkyloxy, selected from methyl, -COOH, -CHO and -COOR b trihaloalkyl - 6 alkyl, C 1 Which may be substituted with 1 to 3 substituents,
Rb는 직쇄형 또는 분지형 C1 - 6알킬인 화합물일 수 있다. R b is a straight or branched C 1 - 6 may be alkyl.
본 발명에서 Et는 에틸을 의미한다. In the present invention, Et means ethyl.
본 발명에 있어서, 특히 바람직한 상기 화학식 1의 화합물은 에틸 (Z)-6-벤질리덴-6H-이소인돌로[2,1-a]인돌-11-카복실레이트;In the present invention, particularly preferred compounds of Formula 1 are ethyl (Z) -6-benzylidene-6H-isoindolo [2,1-a] indole-11-carboxylate;
에틸 (Z)-6-(4-메틸벤질리덴)-6H-이소인돌로[2,1-a]인돌-11-카복실레이트;Ethyl (Z) -6- (4-methylbenzylidene) -6H-isoindolo [2,1-a] indole-11-carboxylate;
에틸 (Z)-6-(4-(메톡시카보닐)벤질리덴)-6H-이소인돌로[2,1-a]인돌-11-카복실레이트;Ethyl (Z) -6- (4- (methoxycarbonyl) benzylidene) -6H-isoindolo [2,1-a] indole-11-carboxylate;
에틸 (Z)-6-(4-포밀벤질리덴)-6H-이소인돌로[2,1-a]인돌-11-카복실레이트;Ethyl (Z) -6- (4-formylbenzylidene) -6H-isoindolo [2,1-a] indole-11-carboxylate;
에틸 (Z)-6-(4-(트리플루오로메틸)벤질리덴)-6H-이소인돌로[2,1-a]인돌-11-카복실레이트;Ethyl (Z) -6- (4- (trifluoromethyl) benzylidene) -6H-isoindolo [2,1-a] indole-11-carboxylate;
에틸 (Z)-6-(4-플루오로벤질리덴)-6H-이소인돌로[2,1-a]인돌-11-카복실레이트; Ethyl (Z) -6- (4-fluorobenzylidene) -6H-isoindolo [2,1-a] indole-11-carboxylate;
에틸 (Z)-6-(2-메틸벤질리덴)-6H-이소인돌로[2,1-a]인돌-11-카복실레이트;Ethyl (Z) -6- (2-methylbenzylidene) -6H-isoindolo [2,1-a] indole-11-carboxylate;
에틸 (Z)-6-(3-메톡시벤질리덴)-6H-이소인돌로[2,1-a]인돌-11-카복실레이트;Ethyl (Z) -6- (3-methoxybenzylidene) -6H-isoindolo [2,1-a] indole-11-carboxylate;
에틸 (Z)-6-(3-클로로벤질리덴)-6H-이소인돌로[2,1-a]인돌-11-카복실레이트;Ethyl (Z) -6- (3-chlorobenzylidene) -6H-isoindolo [2,1-a] indole-11-carboxylate;
에틸 (Z)-6-(3-클로로벤질리덴)-6H-이소인돌로[2,1-a]인돌-11-카복실레이트;Ethyl (Z) -6- (3-chlorobenzylidene) -6H-isoindolo [2,1-a] indole-11-carboxylate;
에틸 (Z)-6-(티오펜-2-일메틸렌)-6H-이소인돌로[2,1-a]인돌-11-카복실레이트; Ethyl (Z) -6- (thiophen-2-ylmethylene) -6H-isoindolo [2,1-a] indole-11-carboxylate;
에틸 (Z)-6-(나프탈렌-2-일메틸렌)-6H-이소인돌로[2,1-a]인돌-11-카복실레이트;Ethyl (Z) -6- (naphthalene-2-ylmethylene) -6H-isoindolo [2,1-a] indole-11-carboxylate;
에틸 (Z)-6-벤질리덴-2-메톡시-6H-이소인돌로[2,1-a]인돌-11-카복실레이트;Ethyl (Z) -6-benzylidene-2-methoxy-6H-isoindolo [2,1-a] indole-11-carboxylate;
에틸 (Z)-6-벤질리덴-2-(트리플루오로메틸)-6H-이소인돌로[2,1-a]인돌-11-카복실레이트;Ethyl (Z) -6-benzylidene-2- (trifluoromethyl) -6H-isoindolo [2,1-a] indole-11-carboxylate;
에틸 (Z)-6-벤질리덴-8-메톡시-6H-이소인돌로[2,1-a]인돌-11-카복실레이트;Ethyl (Z) -6-benzylidene-8-methoxy-6H-isoindolo [2,1-a] indole-11-carboxylate;
에틸 (Z)-6-벤질리덴-8-브로모-6H-이소인돌로[2,1-a]인돌-11-카복실레이트;Ethyl (Z) -6-benzylidene-8-bromo-6H-isoindolo [2,1-a] indole-11-carboxylate;
에틸 5-페닐인돌로[2,1-a]이소퀴놀린-12-카복실레이트;Ethyl 5-phenylindolo [2,1-a] isoquinoline-12-carboxylate;
에틸 5-(p-톨릴)인돌로[2,1-a]이소퀴놀린-12-카복실레이트;Ethyl 5- (p-tolyl) indolo [2,1-a] isoquinoline-12-carboxylate;
에틸 5-(4-(메톡시카보닐)페닐)인돌로[2,1-a]이소퀴놀린-12-카복실레이트;Ethyl 5- (4- (methoxycarbonyl) phenyl) indolo [2,1-a] isoquinoline-12-carboxylate;
에틸 5-(4-포밀페닐)인돌로[2,1-a]이소퀴놀린-12-카복실레이트;Ethyl 5- (4-formylphenyl) indolo [2,1-a] isoquinoline-12-carboxylate;
에틸 5-(4-(트리플루오로메틸)페닐)인돌로[2,1-a]이소퀴놀린-12-카복실레이트;Ethyl 5- (4- (trifluoromethyl) phenyl) indolo [2,1-a] isoquinoline-12-carboxylate;
에틸 5-(4-플루오로페닐)인돌로[2,1-a]이소퀴놀린-12-카복실레이트;Ethyl 5- (4-fluorophenyl) indolo [2,1-a] isoquinoline-12-carboxylate;
에틸 5-(o-톨릴)인돌로[2,1-a]이소퀴놀린-12-카복실레이트;Ethyl 5- (o-tolyl) indolo [2,1-a] isoquinoline-12-carboxylate;
에틸 5-(3-메톡시페닐)인돌로[2,1-a]이소퀴놀린-12-카복실레이트;Ethyl 5- (3-methoxyphenyl) indolo [2,1-a] isoquinoline-12-carboxylate;
에틸 5-(3-클로로페닐)인돌로[2,1-a]이소퀴놀린-12-카복실레이트;Ethyl 5- (3-chlorophenyl) indolo [2,1-a] isoquinoline-12-carboxylate;
에틸 5-헥실인돌로[2,1-a]이소퀴놀린-12-카복실레이트;Ethyl 5-hexylindolo [2,1-a] isoquinoline-12-carboxylate;
에틸 5-(티오펜-2-yl)인돌로[2,1-a]이소퀴놀린-12-카복실레이트;Ethyl 5- (thiophen-2-yl) indolo [2,1-a] isoquinoline-12-carboxylate;
에틸 5-(나프탈렌-2-일)인돌로[2,1-a]이소퀴놀린-12-카복실레이트;Ethyl 5- (naphthalen-2-yl) indolo [2,1-a] isoquinoline-12-carboxylate;
에틸 10-메톡시-5-페닐인돌로[2,1-a]이소퀴놀린-12-카복실레이트;Ethyl 10-methoxy-5-phenylindolo [2,1-a] isoquinoline-12-carboxylate;
에틸 5-페닐-10-(트리플루오로메틸)인돌로[2,1-a]이소퀴놀린-12-카복실레이트;Ethyl 5-phenyl-10- (trifluoromethyl) indolo [2,1-a] isoquinoline-12-carboxylate;
에틸 3-메톡시-5-페닐인돌로[2,1-a]이소퀴놀린-12-카복실레이트; 및Ethyl 3-methoxy-5-phenylindolo [2,1-a] isoquinoline-12-carboxylate; And
에틸 3-브로모-5-페닐인돌로[2,1-a]이소퀴놀린-12-카복실레이트;로 이루어진 군 중에서 선택되는 것일 수 있으나, 이에 한정되는 것은 아니다. Ethyl 3-bromo-5-phenylindolo [2,1-a] isoquinoline-12-carboxylate, but is not limited thereto.
본 발명에 의하면, 상기 반응은 형광을 방출하는 것일 수 있다.According to the present invention, the reaction may be one which emits fluorescence.
본 발명에 의하면, 상기 화학식 2의 화합물은 Z-이성질체 또는 E-이성질체일 수 있다. According to the present invention, the compound of Formula 2 may be a Z-isomer or an E-isomer.
본 발명은 하기 화학식 3의 화합물을 전이금속 촉매하에서 환류시켜 분자 내 고리결합을 형성시키는 것을 포함하는, 상기 화학식 1로 표시되는 화합물의 제조방법을 제공한다:The present invention provides a process for preparing a compound represented by the formula (1), which comprises refluxing a compound of the formula (3) in the presence of a transition metal catalyst to form an intramolecular ring bond:
[화학식 3] (3)
[화학식 1][Chemical Formula 1]
식 중에서,In the formula,
는 단일 또는 이중결합이고, Is a single or double bond,
A는 질소 원자를 포함하는, 5-6원 헤테로시클릭 또는 5-6원 헤테로아릴이고, A is a 5-6 membered heterocyclic or 5-6 membered heteroaryl containing a nitrogen atom,
R1은 수소, 직쇄형 또는 분지형 C1 - 6알킬 및 CO2Ra 중에서 선택되고,R 1 is hydrogen, straight or branched C 1 - 6 alkyl and is selected from CO 2 R a,
R2, R3, R4, R5 및 R6은 서로 동일하거나 또는 상이하고, 각각 독립적으로 수소, 할로, 직쇄형 또는 분지형 C1 - 6알킬, CO2Ra, C1 - 6알킬옥시, 트리할로메틸, 페닐 및 벤질 중에서 선택되고, R 2, R 3, R 4 , R 5 and R 6 are the same or different and each is independently hydrogen, halo, straight or branched C 1 to each other - 6 alkyl, CO 2 R a, C 1 - 6 alkyl Oxy, trihalomethyl, phenyl and benzyl,
R7은 직쇄형 또는 분지형 C1 - 6알킬, C3 - 7시클로알킬, 아릴, 헤테로아릴, 아릴C1-6알킬 및 헤테로아릴C1 - 6알킬 중에서 선택되고; 상기 아릴 또는 아릴C1 - 6알킬의 아릴은 페닐 또는 나프틸이며; 상기 헤테로아릴 또는 헤테로아릴C1 - 6알킬의 헤테로아릴은 N, O 및 S 중에서 선택되는 1 내지 2개의 이종원자를 가지는 5-6원 헤테로아릴, 1H-인돌릴 또는 1H-퀴놀리닐이며; 상기 아릴, 헤테로아릴, 아릴C1 - 6알킬 및 헤테로아릴C1- 6알킬은 각각 독립적으로 비치환되거나 또는 할로, 직쇄형 또는 분지형 C1-6알킬, C1 - 6알킬옥시, 트리할로메틸, -COOH, -CHO, -COORb, 페닐 및 벤질 중에서 선택되는 1 내지 3개의 치환기로 치환될 수 있고,R 7 is straight or branched C 1 - 6 alkyl is selected from 6-alkyl, C 3 - - 7 cycloalkyl, aryl, heteroaryl, aryl C 1-6 alkyl and heteroaryl C 1; And the aryl or aryl C 1 - 6 alkyl, aryl is phenyl or naphthyl; Wherein the heteroaryl or heteroaryl C 1 - 6 alkyl heteroaryl is N, O, and 5-6 membered having from 1 to 2 heteroatoms selected from S-heteroaryl, 1H- indolyl or quinolinyl 1H- and; Wherein the aryl, heteroaryl, aryl C 1 - 6 alkyl and heteroaryl C 1- 6 alkyl, each independently unsubstituted or substituted by halo, straight or branched C 1-6 alkyl, C 1 - 6 alkyloxy, trihalomethyl Romero naphthyl, may be optionally substituted by -COOH, -CHO, -COOR b, phenyl, and 1 to 3 substituents selected from benzyl,
Ra 및 Rb는 서로 동일하거나 또는 상이하고, 각각 독립적으로 직쇄형 또는 분지형 C1 - 6알킬이다.R a and R b are the same or different and each is independently a straight or branched C 1 to each other - a 6 alkyl.
본 발명에 있어서, 상기 반응은 원팟 반응으로 수행되므로, 원자-경제적이다.In the present invention, the reaction is atomic-economical since it is performed in a one-pot reaction.
본 발명에 있어서, 상기 반응은 분자 내 고리화반응일 수 있으며, 구체적으로 CH 결합활성화에 의한 α-첨가반응(5-exo-dig 고리화) 또는 π결합 활성화에 의한 β-첨가반응(6-endo-dig 고리화)일 수 있다. In the present invention, the reaction may be an intramolecular cyclization reaction. Specifically, the reaction may be an α-addition reaction (5-exo-dig cyclization) by CH bond activation or a β- endo-dig cyclization).
본 발명에 있어서, 상기 분자 내 고리화반응의 형태는 반응에 사용되는 전이금속 촉매에 의해 달라질 수 있다. In the present invention, the form of the intramolecular cyclization reaction may vary depending on the transition metal catalyst used in the reaction.
본 발명의 상기 제조방법에서 상기 전이금속 촉매는 Pd(OAc)2, PtCl4 및 AuCl3 중에서 선택되는 것일 수 있다. In the above production method of the present invention, the transition metal catalyst may be selected from Pd (OAc) 2 , PtCl 4 and AuCl 3 .
본 발명의 반응에서 전이금속 촉매가 Pd(OAc)2이면, α-첨가반응(5-exo-dig 고리화)이 형성되어 하기 화학식 2로 표시되는 화합물이 형성되는 것일 수 있다.In the reaction of the present invention, when the transition metal catalyst is Pd (OAc) 2 , an α-addition reaction (5-exo-dig cyclization) may be formed to form a compound represented by Formula 2 below.
[화학식 2](2)
본 발명의 반응에서 전이금속 촉매가 PtCl4 또는 AuCl3이면, β-첨가반응(6-endo-dig 고리화)이 형성되어 상기 화학식 3으로 표시되는 화합물이 형성되는 것일 수 있다.In the reaction of the present invention, when the transition metal catalyst is PtCl 4 or AuCl 3 , a β-addition reaction (6-endo-dig cyclization) may be formed to form the compound represented by Formula 3.
[화학식 3](3)
상기 화학식 2 또는 화학식 3에서, In Formula 2 or Formula 3,
R1, R2, R3, R4, R5 및 R6은 앞에서 제시한 바와 같으며, R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are as previously indicated,
R8은 직쇄형 또는 분지형 C1 - 6알킬, C3 - 7시클로알킬, 아릴 및 헤테로아릴 중에서 선택되고, 상기 아릴은 페닐 또는 나프틸이며; 상기 헤테로아릴은 N, O 및 S 중에서 선택되는 1 내지 2개의 이종원자를 가지는 5-6원 헤테로아릴, 1H-인돌릴 또는 1H-퀴놀리닐이고, 상기 아릴 및 헤테로아릴은 각각 독립적으로 비치환되거나 또는 할로, 직쇄형 또는 분지형 C1 - 6알킬, C1 - 6알킬옥시, 트리할로메틸, -COOH, -CHO, -COORb, 페닐 및 벤질 중에서 선택되는 1 내지 3개의 치환기로 치환될 수 있고,R 8 is straight or branched C 1 - 6 alkyl, C 3 - 7 is selected from cycloalkyl, aryl, and heteroaryl, wherein the aryl is phenyl or naphthyl; Wherein said heteroaryl is 5-6 membered heteroaryl, 1H-indolyl or lH-quinolinyl having 1-2 heteroatoms selected from N, O and S, said aryl and heteroaryl being each independently unsubstituted or substituted or halo, straight or branched C 1 - 6 alkyl, C 1 - 6 alkyl optionally substituted by oxy, methyl, -COOH, -CHO, -COOR b, phenyl and benzyl 1 to 3 substituents selected from trihaloalkyl Can,
Rb는 직쇄형 또는 분지형 C1 - 6알킬이다.R b is a straight or branched C 1 - 6 is alkyl.
본 발명에 의하면 상기 전이금속 촉매가 Pd(OAc)2이면, 반응시 리간드로서 PPh3를 더 포함하는 것이 바람직하며, 보다 바람직하게는 5 내지 20 mol%로 포함되는 것이 바람직하다. According to the present invention, when the transition metal catalyst is Pd (OAc) 2 , PPh 3 is preferably contained as a ligand in the reaction, more preferably 5 to 20 mol%.
본 발명에 의하면, 상기 반응은 유기용매에서 수행될 수 있으며, 상기 유기용매는 특별히 제한은 없으나, C1 - 4알콜, 톨루엔, 아세토니트릴, 디클로로메탄, 디클로로에탄, 테트라하이드로퓨란, 에틸아세테이트, 1,4-디옥산, N,N-디메틸포름아미드 및 디메틸설폭사이드로 이루어진 군으로부터 선택되는 것일 수 있으며, 바람직하게는 톨루엔인 것이 부반응이 적고 반응 수율이 우수하다. According to the present invention, the reaction can take place in an organic solvent, the organic solvent is not particularly limited, C 1 - 4 alcohols, toluene, acetonitrile, dichloromethane, dichloroethane, tetrahydrofuran, ethyl acetate, 1 , 4-dioxane, N, N-dimethylformamide, and dimethylsulfoxide, and toluene is preferable because of less side reaction and excellent reaction yield.
본 발명에 의하면, 상기 반응은 환류조건에서 수행될 수 있으며, 바람직하게는 70 내지 120 ℃에서 수행될 수 있다. According to the present invention, the reaction can be carried out under reflux conditions, preferably at 70 to 120 ° C.
본 발명에 의하면, 상기 α-첨가반응은 수분 내에 완료될 수 있으며, 상기 β-첨가반응은 수분 내지 수시간 내에 완료될 수 있다. According to the present invention, the? -Adding reaction can be completed within a few minutes, and the? -Adding reaction can be completed within several minutes to several hours.
본 발명에 의하면, 상기 전이금속 촉매는 2 내지 20 mol%로 첨가되는 것일 수 있다. According to the present invention, the transition metal catalyst may be added in an amount of 2 to 20 mol%.
본 발명에 의하면, 상기 화학식 2로 표시되는 화합물은 Z-이성질체로 제조될 수 있으며, 산처리함으로써 E-이성질체로 변환시킬 수 있다. 상기 산처리는 통상적으로 이성질화에 사용되는 것이면 특별히 제한은 없으며, 예를 들어 HCl 수용액에서 반응시키는 것일 수 있고, 반응시 가열하는 과정을 더 포함하여 수행함으로써 달성될 수 있다. According to the present invention, the compound represented by Formula 2 may be prepared as a Z-isomer and converted to an E-isomer by acid treatment. The acid treatment is not particularly limited as long as it is usually used for isomerization. For example, the acid treatment may be carried out in an aqueous solution of HCl, and the reaction may be further carried out by heating.
본 발명에 따른 상기 화학식 2로 표시되는 화합물은 이중결합을 치환함으로써 다양한 화합물을 제조하는 중간체로 사용될 수 있다. The compound represented by Formula 2 according to the present invention can be used as an intermediate for preparing various compounds by substituting a double bond.
본 발명에 따른 화합물을 중간체로 사용하는 예로는 다음과 같은 반응들이 있을 수 있으나, 하기와 같은 반응은 예시일 뿐 이에 한정되는 것은 아니다. Examples of the use of the compound according to the present invention as an intermediate include the following reactions, but the following reactions are illustrative and not intended to be limiting.
실시예Example
이하, 바람직한 실시예를 들어 본 발명을 더욱 상세하게 설명한다. 그러나 이들 실시예는 본 발명을 보다 구체적으로 성명하기 위한 것으로, 본 발명의 범위가 이에 의하여 제한되지 않는다는 것은 당업계의 통상의 지식을 가진 자에게 자명할 것이다. Hereinafter, the present invention will be described in more detail with reference to preferred embodiments. It will be apparent to those skilled in the art, however, that these examples are for the purpose of describing the present invention more specifically and that the scope of the present invention is not limited thereby.
실시예 1. 에틸 (Z)-6-벤질리덴-6H-이소인돌로[2,1-a]인돌-11-카복실레이트의 합성Example 1. Synthesis of ethyl (Z) -6-benzylidene-6H-isoindolo [2,1-a] indole-11-carboxylate
인돌 아인아마이드인 에틸 2-페닐-1-(페닐에티닐)-1H-인돌-3-카복실레이트 (73.1 mg, 0.2 mmol), Pd(OAc)2 (2.3 mg, 0.01 mmol), PPh3 (5.3 mg, 0.02 mmol)와 톨루엔 (1 mL)을 캡이 달린 바이알에 넣었다. 반응 혼합물을 알루미늄 블록 안에서 80 ℃로 교반하면서 1H NMR 상에서 출발물질이 없어지는 것이 확인될 때까지 반응(10~60분간)시켰다. 실온으로 냉각한 후, 반응 혼합물을 즉시 2-3 방울의 암모니아수를 염기로 추가된 헥산:에테르=9:1로 로딩된 실리카겔 컬럼에 넣어준 뒤, 동일한 용매로 정제하여 목적하는 화합물을 수득하였다. 이성질체가 형성되는 것을 피하기 위해, 반응이 종료된 직후에 정제하였으며, 상온에서는 서서히 이성질화 되는 경향이 있기 때문에 -20 ℃이하의 온도에서 보관하였다.Indole-3-carboxylate (73.1 mg, 0.2 mmol), Pd (OAc) 2 (2.3 mg, 0.01 mmol), PPh 3 mg, 0.02 mmol) and toluene (1 mL) were placed in a capped vial. The reaction mixture was stirred (at 80 < 0 > C) in an aluminum block and allowed to react (10-60 min) until the starting material was confirmed to be complete by 1 H NMR. After cooling to room temperature, the reaction mixture was immediately added to a silica gel column loaded with 2-3 drops of ammonia water as a base, added with hexane: ether = 9: 1, and then purified with the same solvent to obtain the desired compound. To avoid isomer formation, the reaction was refined immediately after the reaction was terminated, and was stored at a temperature below -20 캜 because it tends to be isomerized slowly at room temperature.
반응시간 5분, 수율 99%, 노란색 고체Reaction time 5 min, yield 99%, yellow solid
M.p. = 157-158 ℃; 1H NMR (300 MHz, CDCl3) δ 8.77-8.68 (m, 1H), 8.18 (d, J = 7.9 Hz, 1H), 7.73 (d, J = 6.9 Hz, 1H), 7.55-7.33 (m, 7H), 7.14 (t, J = 7.4 Hz, 1H), 7.05 (s, 1H), 6.88-6.77 (m, 1H), 6.04 (d, J = 8.4 Hz, 1H), 4.53 (q, J = 7.1 Hz, 2H), 1.54 (t, J = 7.1 Hz, 3H); 13C NMR (151 MHz, CDCl3) δ 165.1, 148.0, 140.5, 135.6, 134.0, 132.5, 131.6, 130.1, 129.2, 129.0, 128.5, 128.1, 125.4, 122.8, 122.4, 119.9, 114.9, 109.3, 102.9, 60.1, 14.6 (two carbon peaks are overlapped); IR (ATR): 3049, 2972, 1688, 1600, 1565, 1438 cm-1; HRMS (ESI) calcd for C25H19NO2 [M + H]+ 366.1489, found 366.1490.Mp = 157-158 DEG C; 1 H NMR (300 MHz, CDCl 3) δ 8.77-8.68 (m, 1H), 8.18 (d, J = 7.9 Hz, 1H), 7.73 (d, J = 6.9 Hz, 1H), 7.55-7.33 (m, 7H), 7.14 (t, J = 7.4 Hz, 1H), 7.05 (s, 1H), 6.88-6.77 (m, 1H), 6.04 (d, J = 8.4 Hz, 1H), 4.53 (q, J = 7.1 Hz, 2H), 1.54 (t, J = 7.1 Hz, 3H); 13 C NMR (151 MHz, CDCl 3) δ 165.1, 148.0, 140.5, 135.6, 134.0, 132.5, 131.6, 130.1, 129.2, 129.0, 128.5, 128.1, 125.4, 122.8, 122.4, 119.9, 114.9, 109.3, 102.9, 60.1 , 14.6 (two carbon peaks are overlapped); IR (ATR): 3049, 2972, 1688, 1600, 1565, 1438 cm < -1 & gt ;; HRMS (ESI) calcd for C 25 H 19 NO 2 [M + H] + 366.1489, found 366.1490.
실시예 2. 에틸 (Z)-6-(4-메틸벤질리덴)-6H-이소인돌로[2,1-a]인돌-11-카복실레이트의 합성Synthesis of ethyl (Z) -6- (4-methylbenzylidene) -6H-isoindolo [2,1-a] indole-11-carboxylate
반응시간 10분, 수율 92%, 노란색 고체Reaction time 10 min, yield 92%, yellow solid
M.p. = 143-148 ℃; 1H NMR (300 MHz, CDCl3) δ 8.73 (d, J = 7.4 Hz, 1H), 8.20 (d, J = 8.0 Hz, 1H), 7.72 (d, J = 6.9 Hz, 1H), 7.46 (dd, J = 13.8, 7.0 Hz, 2H), 7.21 (dt, J = 17.8, 7.9 Hz, 5H), 7.01 (s, 1H), 6.87 (t, J = 7.6 Hz, 1H), 6.16 (d, J = 8.4 Hz, 1H), 4.54 (q, J = 14.2, 7.1 Hz, 2H), 2.43 (s, 3H), 1.55 (t, J = 7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 165.1, 147.9, 140.5, 138.0, 133.3, 132.4, 132.3, 131.5, 129.9, 129.1, 128.9, 128.8, 125.3, 122.6, 122.3, 119.7, 115.1, 109.6, 102.5, 60.1, 21.4, 14.6 (two carbon peaks are overlapped); IR (ATR): 3053, 2956, 1666, 1562, 1443, 1407, 1383, 1154 cm-1; HRMS (ESI) calcd for C26H21NO2 [M + H]+ 380.1645, found 380.1646.Mp = 143-148 DEG C; 1 H NMR (300 MHz, CDCl 3) δ 8.73 (d, J = 7.4 Hz, 1H), 8.20 (d, J = 8.0 Hz, 1H), 7.72 (d, J = 6.9 Hz, 1H), 7.46 (dd , J = 13.8, 7.0 Hz, 2H), 7.21 (dt, J = 17.8, 7.9 Hz, 5H), 7.01 (s, 1H), 6.87 (t, J = 7.6 Hz, 1H), 6.16 (d, J = 8.4 Hz, 1H), 4.54 (q, J = 14.2, 7.1 Hz, 2H), 2.43 (s, 3H), 1.55 (t, J = 7.1 Hz, 3H); 13 C NMR (75 MHz, CDCl 3) δ 165.1, 147.9, 140.5, 138.0, 133.3, 132.4, 132.3, 131.5, 129.9, 129.1, 128.9, 128.8, 125.3, 122.6, 122.3, 119.7, 115.1, 109.6, 102.5, 60.1 , 21.4, 14.6 (two carbon peaks are overlapped); IR (ATR): 3053, 2956, 1666, 1562, 1443, 1407, 1383, 1154 cm -1 ; HRMS (ESI) calcd for C 26 H 21 NO 2 [M + H] + 380.1645, found 380.1646.
실시예 3. 에틸 (Z)-6-(4-(메톡시카보닐)벤질리덴)-6H-이소인돌로[2,1-a]인돌-11-카복실레이트의 합성Example 3. Synthesis of ethyl (Z) -6- (4- (methoxycarbonyl) benzylidene) -6H-isoindolo [2,1-a] indole-11-carboxylate
반응시간 15분, 수율 93%, 노란색 고체Reaction time 15 min, yield 93%, yellow solid
M.p. = 121-123 ℃; 1H NMR (300 MHz, CDCl3) δ 8.72 (d, J = 7.3 Hz, 1H), 8.18 (d, J = 8.2 Hz, 1H), 8.07 (d, J = 8.3 Hz, 2H), 7.75 (d, J = 7.7 Hz, 1H), 7.54-7.39 (m, 4H), 7.15 (t, J = 7.6 Hz, 1H), 7.01 (s, 1H), 6.86 (t, J = 7.8 Hz, 1H), 6.05 (d, J = 8.4 Hz, 1H), 4.53 (q, J = 7.1 Hz, 2H), 3.96 (s, 3H), 53 (t, J = 7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 166.6, 164.9, 147.9, 140.3, 140.2, 134.7, 132.2, 131.5, 130.0, 129.9, 129.6, 129.5, 129.2, 129.1, 125.5, 123.1, 122.7, 122.6, 120.1, 114.9, 107.7, 103.5, 60.2, 52.2, 14.6; IR (ATR): 3054, 2920, 2850, 1716, 1668, 1602, 1563, 1469, 1440 cm-1; HRMS (ESI) calcd for C27H21NO4 [M + H]+ 424.1543, found 424.1545.Mp = 121-123 DEG C; 1 H NMR (300 MHz, CDCl 3) δ 8.72 (d, J = 7.3 Hz, 1H), 8.18 (d, J = 8.2 Hz, 1H), 8.07 (d, J = 8.3 Hz, 2H), 7.75 (d , J = 7.7 Hz, 1H) , 7.54-7.39 (m, 4H), 7.15 (t, J = 7.6 Hz, 1H), 7.01 (s, 1H), 6.86 (t, J = 7.8 Hz, 1H), 6.05 (d, J = 8.4 Hz, 1H), 4.53 (q, J = 7.1 Hz, 2H), 3.96 (s, 3H), 53 (t, J = 7.1 Hz, 3H); 13 C NMR (75 MHz, CDCl 3) δ 166.6, 164.9, 147.9, 140.3, 140.2, 134.7, 132.2, 131.5, 130.0, 129.9, 129.6, 129.5, 129.2, 129.1, 125.5, 123.1, 122.7, 122.6, 120.1, 114.9 , 107.7, 103.5, 60.2, 52.2, 14.6; IR (ATR): 3054, 2920, 2850, 1716, 1668, 1602, 1563, 1469, 1440 cm -1 ; HRMS (ESI) calcd for C 27 H 21 NO 4 [M + H] + 424.1543, found 424.1545.
실시예 4. 에틸 (Z)-6-(4-포밀벤질리덴)-6H-이소인돌로[2,1-a]인돌-11-카복실레이트의 합성Example 4. Synthesis of ethyl (Z) -6- (4-formylbenzylidene) -6H-isoindolo [2,1-a] indole-11-carboxylate
반응시간 15분, 수율 96%, 노란색 고체Reaction time 15 min, yield 96%, yellow solid
M.p. = 132-134 ℃; 1H NMR (300 MHz, CDCl3) δ 10.04 (s, 1H), 8.72 (d, J = 7.0 Hz, 1H), 8.19 (d, J = 7.9 Hz, 1H), 7.90 (d, J = 8.0 Hz, 2H), 7.72 (dd, J = 21.3, 7.4 Hz, 2H), 7.49 (dd, J = 16.2, 7.7 Hz, 3H), 7.20-7.08 (m, 1H), 7.00 (s, 1H), 6.91-6.77 (m, 1H), 6.04 (d, J = 7.9 Hz, 1H), 4.61-4.43 (m, 2H), 1.63-1.44 (m, 3H); 13C NMR (75 MHz, CDCl3) δ 191.3, 164.8, 147.9, 141.9, 140.4, 135.4, 135.3, 132.4, 131.7, 130.6, 129.8, 129.7, 129.4, 129.1, 125.6, 123.2, 122.9, 122.8, 120.1, 114.8, 107.2, 104.0, 60.2, 14.6; IR (ATR): 3047, 2921, 2851, 1685, 1652, 1561, 1441, 1146 cm-1; HRMS (ESI) calcd for C26H19NO3 [M + H]+ 394.1438, found 394.1434.Mp = 132-134 [deg.] C; 1 H NMR (300 MHz, CDCl 3) δ 10.04 (s, 1H), 8.72 (d, J = 7.0 Hz, 1H), 8.19 (d, J = 7.9 Hz, 1H), 7.90 (d, J = 8.0 Hz 2H), 7.72 (dd, J = 21.3, 7.4 Hz, 2H), 7.49 (dd, J = 16.2,7.7 Hz, 3H), 7.20-7.08 6.77 (m, 1H), 6.04 (d, J = 7.9 Hz, 1H), 4.61-4.43 (m, 2H), 1.63-1.44 (m, 3H); 13 C NMR (75 MHz, CDCl 3) δ 191.3, 164.8, 147.9, 141.9, 140.4, 135.4, 135.3, 132.4, 131.7, 130.6, 129.8, 129.7, 129.4, 129.1, 125.6, 123.2, 122.9, 122.8, 120.1, 114.8 , 107.2, 104.0, 60.2, 14.6; IR (ATR): 3047, 2921, 2851, 1685, 1652, 1561, 1441, 1146 cm < -1 & gt ;; HRMS (ESI) calcd for C 26 H 19 NO 3 [M + H] + 394.1438, found 394.1434.
실시예 5. 에틸 (Z)-6-(4-(트리플루오로메틸)벤질리덴)-6H-이소인돌로[2,1-a]인돌-11-카복실레이트의 합성Example 5. Synthesis of ethyl (Z) -6- (4- (trifluoromethyl) benzylidene) -6H-isoindolo [2,1-a] indole-11-carboxylate
반응시간 10분, 수율 96%, 노란색 고체Reaction time 10 min, yield 96%, yellow solid
M.p. = 152-154 ℃; 1H NMR (300 MHz, CDCl3) δ 8.68 (d, J = 7.5 Hz, 1H), 8.17 (d, J = 8.0 Hz, 1H), 7.75-7.55 (m, 3H), 7.55-7.33 (m, 4H), 7.15 (t, J = 7.6 Hz, 1H), 6.91 (s, 1H), 6.84 (t, J = 7.8 Hz, 1H), 5.90 (d, J = 8.4 Hz, 1H), 4.51 (q, J = 7.1 Hz, 2H), 1.53 (t, J = 7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 164.9, 147.9, 140.2, 139.2, 134.9, 132.2, 131.6, 130.3, 129.9 (q, J F -C = 32.25 Hz), 129.6, 129.2, 129.1, 125.5, 125.3 (q, J F -C = 3.75 Hz), 124.0 (q, J F -C = 270.75 Hz), 123.1, 122.7, 122.7, 120.0, 114.7, 106.9, 103.6, 60.3, 14.6; IR (ATR): 3055, 2986, 2921, 1694, 1582, 1441, 1318 cm-1; HRMS (ESI) calcd for C26H18F3NO2 [M + H]+ 434.1362, found 434.1362.Mp = 152-154 DEG C; 1 H NMR (300 MHz, CDCl 3) δ 8.68 (d, J = 7.5 Hz, 1H), 8.17 (d, J = 8.0 Hz, 1H), 7.75-7.55 (m, 3H), 7.55-7.33 (m, 4H), 7.15 (t, J = 7.6 Hz, 1H), 6.91 (s, 1H), 6.84 (t, J = 7.8 Hz, 1H), 5.90 (d, J = 8.4 Hz, 1H), 4.51 (q, J = 7.1 Hz, 2H), 1.53 (t, J = 7.1 Hz, 3H); 13 C NMR (75 MHz, CDCl 3) δ 164.9, 147.9, 140.2, 139.2, 134.9, 132.2, 131.6, 130.3, 129.9 (q, J F -C = 32.25 Hz), 129.6, 129.2, 129.1, 125.5, 125.3 ( q, J F -C = 3.75 Hz ), 124.0 (q, J F -C = 270.75 Hz), 123.1, 122.7, 122.7, 120.0, 114.7, 106.9, 103.6, 60.3, 14.6; IR (ATR): 3055, 2986, 2921, 1694, 1582, 1441, 1318 cm -1 ; HRMS (ESI) calcd for C 26 H 18 F 3 NO 2 [M + H] + 434.1362, found 434.1362.
실시예 6. 에틸 (Z)-6-(4-플루오로벤질리덴)-6H-이소인돌로[2,1-a]인돌-11-카복실레이트의 합성Example 6. Synthesis of ethyl (Z) -6- (4-fluorobenzylidene) -6H-isoindolo [2,1-a] indole-11-carboxylate
반응시간 10분, 수율 92%, 노란색 고체Reaction time 10 min, yield 92%, yellow solid
M.p. = 121-125 ℃; 1H NMR (300 MHz, CDCl3) δ 8.68 (d, J = 7.4 Hz, 1H), 8.18 (d, J = 8.0 Hz, 1H), 7.64 (d, J = 7.5 Hz, 1H), 7.50-7.34 (m, 2H), 7.35-7.23 (m, 2H), 7.16 (t, J = 7.7 Hz, 1H), 7.07 (t, J = 8.6 Hz, 2H), 6.93-6.81 (m, 2H), 6.05 (d, J = 8.4 Hz, 1H), 4.58-4.41 (m, 2H), 1.60-1.44 (m, 3H); 13C NMR (75 MHz, CDCl3) δ 165.0, 162.2 (d, J F -C = 247.5 Hz), 147.9, 140.3, 133.8, 132.2, 131.7 (d, J F -C = 8.25 Hz), 131.5, 131.4, 131.4, 129.2, 128.9, 128.9, 125.3, 122.8, 122.5 (d, J F -C = 3.75 Hz), 119.8, 115.5 (d, J F -C = 21.7 Hz), 114.7, 107.9, 102.8, 60.1, 14.6; IR (ATR): 3046, 2975, 1670, 1562, 1504, 1441 cm-1; HRMS (ESI) calcd for C25H18FNO2 [M + H]+ 384.1394, found 384.1399.Mp = 121-125 DEG C; 1 H NMR (300 MHz, CDCl 3) δ 8.68 (d, J = 7.4 Hz, 1H), 8.18 (d, J = 8.0 Hz, 1H), 7.64 (d, J = 7.5 Hz, 1H), 7.50-7.34 (m, 2H), 7.35-7.23 ( m, 2H), 7.16 (t, J = 7.7 Hz, 1H), 7.07 (t, J = 8.6 Hz, 2H), 6.93-6.81 (m, 2H), 6.05 ( d, J = 8.4 Hz, 1H), 4.58-4.41 (m, 2H), 1.60-1.44 (m, 3H); 13 C NMR (75 MHz, CDCl 3) δ 165.0, 162.2 (d, J F -C = 247.5 Hz), 147.9, 140.3, 133.8, 132.2, 131.7 (d, J F -C = 8.25 Hz), 131.5, 131.4 , 131.4, 129.2, 128.9, 128.9 , 125.3, 122.8, 122.5 (d, J F -C = 3.75 Hz), 119.8, 115.5 (d, J F -C = 21.7 Hz), 114.7, 107.9, 102.8, 60.1, 14.6 ; IR (ATR): 3046, 2975, 1670, 1562, 1504, 1441 cm < -1 & gt ;; HRMS (ESI) calcd for C 25 H 18 FNO 2 [M + H] + 384.1394, found 384.1399.
실시예 7. 에틸 (Z)-6-(2-메틸벤질리덴)-6H-이소인돌로[2,1-a]인돌-11-카복실레이트의 합성Example 7. Synthesis of ethyl (Z) -6- (2-methylbenzylidene) -6H-isoindolo [2,1-a] indole-11-carboxylate
실시예 1과 동일한 방법으로 반응하되, 반응 30분 후, 5 mol% Pd(OAc)2 및 10 mol% PPh3를 더 추가하였다. The reaction was carried out in the same manner as in Example 1, and 30 minutes after the reaction, 5 mol% Pd (OAc) 2 and 10 mol% PPh 3 were further added.
반응시간 60분, 수율 89%, 갈색 고체Reaction time 60 min, yield 89%, brown solid
M.p. = 113-115 ℃; 1H NMR (300 MHz, CDCl3) δ 8.75 (d, J = 7.0 Hz, 1H), 8.16 (d, J = 7.8 Hz, 1H), 7.78 (d, J = 6.8 Hz, 1H), 7.53-7.40 (m, 2H), 7.33 (s, 2H), 7.22 (d, J = 13.0 Hz, 2H), 7.11 (t, J = 7.5 Hz, 1H), 7.02 (s, 1H), 6.75 (t, J = 7.6 Hz, 1H), 5.83 (d, J = 8.3 Hz, 1H), 4.52 (dd, J = 13.8, 6.8 Hz, 2H), 2.34 (s, 3H), 1.53 (t, J = 6.9 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 165.2, 147.8, 140.1, 137.5, 135.2, 134.8, 132.6, 131.4, 130.6, 130.2, 129.3, 129.2, 128.9, 128.5, 125.9, 125.4, 123.1, 122.4, 122.3, 120.0, 113.9, 108.4, 102.6, 60.1, 20.2, 14.6; IR (ATR): 2963, 2925, 1686, 1554, 1510, 1444, 1379 cm-1; HRMS (ESI) calcd for C26H21NO2 [M + H]+ 380.1645, found 380.1644.Mp = 113-115 DEG C; 1 H NMR (300 MHz, CDCl 3) δ 8.75 (d, J = 7.0 Hz, 1H), 8.16 (d, J = 7.8 Hz, 1H), 7.78 (d, J = 6.8 Hz, 1H), 7.53-7.40 (m, 2H), 7.33 ( s, 2H), 7.22 (d, J = 13.0 Hz, 2H), 7.11 (t, J = 7.5 Hz, 1H), 7.02 (s, 1H), 6.75 (t, J = 7.6 Hz, 1H), 5.83 ( d, J = 8.3 Hz, 1H), 4.52 (dd, J = 13.8, 6.8 Hz, 2H), 2.34 (s, 3H), 1.53 (t, J = 6.9 Hz, 3H) ; 13 C NMR (75 MHz, CDCl 3) δ 165.2, 147.8, 140.1, 137.5, 135.2, 134.8, 132.6, 131.4, 130.6, 130.2, 129.3, 129.2, 128.9, 128.5, 125.9, 125.4, 123.1, 122.4, 122.3, 120.0 , 113.9, 108.4, 102.6, 60.1, 20.2, 14.6; IR (ATR): 2963, 2925, 1686, 1554, 1510, 1444, 1379 cm < -1 & gt ;; HRMS (ESI) calcd for C 26 H 21 NO 2 [M + H] + 380.1645, found 380.1644.
실시예 8. 에틸 (Z)-6-(3-메톡시벤질리덴)-6H-이소인돌로[2,1-a]인돌-11-카복실레이트의 합성Example 8. Synthesis of ethyl (Z) -6- (3-methoxybenzylidene) -6H-isoindolo [2,1-a] indole-11-carboxylate
반응시간 15분, 수율 99%, 갈색 고체Reaction time 15 min, yield 99%, brown solid
M.p. = 120-124 ℃; 1H NMR (300 MHz, CDCl3) δ 8.70 (d, J = 7.3 Hz, 1H), 8.19 (d, J = 7.9 Hz, 1H), 7.66 (d, J = 7.4 Hz, 1H), 7.50-7.33 (m, 2H), 7.29 (t, J = 7.8 Hz, 1H), 7.13 (dd, J = 18.0, 10.5 Hz, 1H), 7.01-6.80 (m, 5H), 6.11 (d, J = 8.3 Hz, 1H), 4.53 (dd, J = 14.1, 7.0 Hz, 2H), 3.68 (s, 3H), 1.54 (t, J = 7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 164.9, 159.5, 147.8, 140.4, 136.7, 134.0, 132.4, 131.5, 129.4, 129.1, 128.9, 125.4, 122.8, 122.6, 122.4, 122.4, 119.8, 115.0, 114.7, 114.4, 109.1, 102.9, 60.0, 55.1, 14.6 (one carbon peak is overlapped); IR (ATR): 3046, 2972, 2899, 1672, 1558, 1467, 1438 cm-1; HRMS (ESI) calcd for C26H21NO3 [M + H]+ 396.1594, found 396.1597.Mp = 120-124 DEG C; 1 H NMR (300 MHz, CDCl 3) δ 8.70 (d, J = 7.3 Hz, 1H), 8.19 (d, J = 7.9 Hz, 1H), 7.66 (d, J = 7.4 Hz, 1H), 7.50-7.33 (m, 2H), 7.29 ( t, J = 7.8 Hz, 1H), 7.13 (dd, J = 18.0, 10.5 Hz, 1H), 7.01-6.80 (m, 5H), 6.11 (d, J = 8.3 Hz, 1H), 4.53 (dd, J = 14.1, 7.0 Hz, 2H), 3.68 (s, 3H), 1.54 (t, J = 7.1 Hz, 3H); 13 C NMR (75 MHz, CDCl 3) δ 164.9, 159.5, 147.8, 140.4, 136.7, 134.0, 132.4, 131.5, 129.4, 129.1, 128.9, 125.4, 122.8, 122.6, 122.4, 122.4, 119.8, 115.0, 114.7, 114.4 , 109.1, 102.9, 60.0, 55.1, 14.6 (one carbon peak is overlapped); IR (ATR): 3046, 2972, 2899, 1672, 1558, 1467, 1438 cm -1 ; HRMS (ESI) calcd for C 26 H 21 NO 3 [M + H] + 396.1594, found 396.1597.
실시예 9. 에틸 (Z)-6-(3-클로로벤질리덴)-6H-이소인돌로[2,1-a]인돌-11-카복실레이트의 합성Example 9. Synthesis of ethyl (Z) -6- (3-chlorobenzylidene) -6H-isoindolo [2,1-a] indole-11-carboxylate
반응시간 15분, 수율 83%, 노란색 고체Reaction time 15 min, yield 83%, yellow solid
M.p. = 134-135 ℃; 1H NMR (300 MHz, CDCl3) δ 8.66 (d, J = 7.4 Hz, 1H), 8.17 (d, J = 7.9 Hz, 1H), 7.62 (d, J = 7.4 Hz, 1H), 7.52-7.04 (m, 7H), 7.26-7.23 (m, 1H), 6.92-6.83 (m, 1H), 6.82 (s, 1H), 6.01 (d, J = 8.3 Hz, 1H), 4.66-4.30 (m, 3H), 1.52 (t, J = 7.0 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 164.9, 147.8, 140.2, 137.2, 134.4, 134.3, 132.2, 131.5, 129.7, 129.5, 129.4, 129.1, 128.9, 128.1, 128.0, 125.4, 123.0, 122.6, 122.5, 119.9, 114.7, 107.2, 103.2, 60.2, 14.6; IR (ATR): 3043, 2922, 2853, 1670, 1559, 1468, 1444 cm-1; HRMS (ESI) calcd for C25H18ClNO2 [M + H]+ 400.1099, found 400.1099.Mp = 134-135 < 0 >C; 1 H NMR (300 MHz, CDCl 3) δ 8.66 (d, J = 7.4 Hz, 1H), 8.17 (d, J = 7.9 Hz, 1H), 7.62 (d, J = 7.4 Hz, 1H), 7.52-7.04 (m, 7H), 7.26-7.23 (m, IH), 6.92-6.83 (m, IH), 6.82 (s, IH), 6.01 (d, J = 8.3 Hz, ), 1.52 (t, J = 7.0 Hz, 3H); 13 C NMR (75 MHz, CDCl 3) δ 164.9, 147.8, 140.2, 137.2, 134.4, 134.3, 132.2, 131.5, 129.7, 129.5, 129.4, 129.1, 128.9, 128.1, 128.0, 125.4, 123.0, 122.6, 122.5, 119.9 , 114.7, 107.2, 103.2, 60.2, 14.6; IR (ATR): 3043, 2922, 2853, 1670, 1559, 1468, 1444 cm < -1 & gt ;; HRMS (ESI) calcd for C 25 H 18 ClNO 2 [M + H] + 400.1099, found 400.1099.
실시예 10. 에틸 (Z)-6-(3-클로로벤질리덴)-6H-이소인돌로[2,1-a]인돌-11-카복실레이트의 합성Example 10. Synthesis of ethyl (Z) -6- (3-chlorobenzylidene) -6H-isoindolo [2,1-a] indole-11-carboxylate
반응시간 10분, 수율 98%, 연노란색 고체Reaction time 10 min, yield 98%, pale yellow solid
M.p. = 68-71 ℃; 1H NMR (300 MHz, CDCl3) δ 8.69 (d, J = 7.0 Hz, 1H), 8.25 (d, J = 4.8 Hz, 1H), 7.80 (d, J = 7.6 Hz, 1H), 7.56 (d, J = 7.1 Hz, 1H), 7.40 (dd, J = 15.4, 7.2 Hz, 2H), 7.27 (dd, J = 8.9, 5.1 Hz, 2H), 5.84 (t, J = 6.9 Hz, 1H), 4.51 (dd, J = 13.7, 6.7 Hz, 2H), 2.84 (dd, J = 13.8, 6.9 Hz, 2H), 1.73-1.19 (m, 11H), 0.92 (t, 3H); 13C NMR (75 MHz, CDCl3) δ 165.2, 147.5, 139.9, 133.8, 132.8, 131.5, 128.6, 128.4, 128.2, 125.1, 122.9, 122.6, 122.3, 119.2, 112.7, 112.1, 101.3, 60.0, 31.6, 30.4, 29.9, 29.0, 22.5, 14.6, 14.0; IR (ATR): 3049, 2924, 2854, 1694, 1571, 1443 cm-1; HRMS (ESI) calcd for C25H27NO2 [M + H]+ 374.2115, found 374.2113.Mp = 68-71 DEG C; 1 H NMR (300 MHz, CDCl 3) δ 8.69 (d, J = 7.0 Hz, 1H), 8.25 (d, J = 4.8 Hz, 1H), 7.80 (d, J = 7.6 Hz, 1H), 7.56 (d , J = 7.1 Hz, 1H) , 7.40 (dd, J = 15.4, 7.2 Hz, 2H), 7.27 (dd, J = 8.9, 5.1 Hz, 2H), 5.84 (t, J = 6.9 Hz, 1H), 4.51 (dd, J = 13.7, 6.7 Hz, 2H), 2.84 (dd, J = 13.8, 6.9 Hz, 2H), 1.73-1.19 (m, 11H), 0.92 (t, 3H); 13 C NMR (75 MHz, CDCl 3) δ 165.2, 147.5, 139.9, 133.8, 132.8, 131.5, 128.6, 128.4, 128.2, 125.1, 122.9, 122.6, 122.3, 119.2, 112.7, 112.1, 101.3, 60.0, 31.6, 30.4 , 29.9, 29.0, 22.5, 14.6, 14.0; IR (ATR): 3049, 2924, 2854, 1694, 1571, 1443 cm < -1 & gt ;; HRMS (ESI) calcd for C 25 H 27 NO 2 [M + H] + 374.2115, found 374.2113.
실시예 11. 에틸 (Z)-6-(티오펜-2-일메틸렌)-6H-이소인돌로[2,1-a]인돌-11-카복실레이트의 합성Example 11. Synthesis of ethyl (Z) -6- (thiophen-2-ylmethylene) -6H-isoindolo [2,1-a] indole-11-carboxylate
반응시간 15분, 수율 95%, 갈색 고체Reaction time 15 min, yield 95%, brown solid
M.p. = 142-144 ℃; 1H NMR (300 MHz, CDCl3) δ 8.66 (d, J = 7.5 Hz, 1H), 8.19 (d, J = 8.0 Hz, 1H), 7.61 (d, J = 7.3 Hz, 1H), 7.49-7.33 (m, 3H), 7.18 (t, J = 7.6 Hz, 1H), 7.10-7.02 (m, 1H), 6.96 (d, J = 8.1 Hz, 2H), 6.86 (s, 1H), 6.20 (d, J = 8.3 Hz, 1H), 4.51 (q, J = 7.1 Hz, 2H), 1.54 (t, J = 7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 164.9, 147.8, 140.0, 137.0, 134.7, 132.2, 131.5, 129.5, 129.2, 128.9, 128.9, 127.4, 127.1, 125.3, 122.9, 122.5, 122.5, 119.9, 114.8, 103.1, 101.3, 60.1, 14.6; IR (ATR): 3050, 2922, 2851, 1669, 1559, 1471, 1442, 1403 cm-1; HRMS (ESI) calcd for C23H17NO2S [M + H]+ 372.1053, found 372.1057.Mp = 142-144 DEG C; 1 H NMR (300 MHz, CDCl 3) δ 8.66 (d, J = 7.5 Hz, 1H), 8.19 (d, J = 8.0 Hz, 1H), 7.61 (d, J = 7.3 Hz, 1H), 7.49-7.33 (m, 3H), 7.18 (t, J = 7.6 Hz, IH), 7.10-7.02 (m, IH), 6.96 (d, J = 8.1 Hz, 2H), 6.86 J = 8.3 Hz, 1H), 4.51 (q, J = 7.1 Hz, 2H), 1.54 (t, J = 7.1 Hz, 3H); 13 C NMR (75 MHz, CDCl 3) δ 164.9, 147.8, 140.0, 137.0, 134.7, 132.2, 131.5, 129.5, 129.2, 128.9, 128.9, 127.4, 127.1, 125.3, 122.9, 122.5, 122.5, 119.9, 114.8, 103.1 , 101.3, 60.1, 14.6; IR (ATR): 3050, 2922, 2851, 1669, 1559, 1471, 1442, 1403 cm < -1 & gt ;; HRMS (ESI) calcd for C 23 H 17 NO 2 S [M + H] + 372.1053, found 372.1057.
실시예 12. 에틸 (Z)-6-(나프탈렌-2-일메틸렌)-6H-이소인돌로[2,1-a]인돌-11-카복실레이트의 합성Example 12. Synthesis of ethyl (Z) -6- (naphthalene-2-ylmethylene) -6H-isoindolo [2,1-a] indole-11-carboxylate
반응시간 15분, 수율 90%, 노란색 고체Reaction time 15 min, yield 90%, yellow solid
M.p. = 162-164 ℃; 1H NMR (300 MHz, CDCl3) δ 8.73 (d, J = 7.5 Hz, 1H), 8.20 (d, J = 7.9 Hz, 1H), 7.82 (dd, J = 18.3, 7.5 Hz, 3H), 7.70 (dd, J = 11.0, 8.3 Hz, 2H), 7.58-7.36 (m, 5H), 7.17-7.08 (m, J = 14.7, 7.4 Hz, 1H), 7.06 (s, 1H), 6.67 (t, J = 7.6 Hz, 1H), 6.13 (d, J = 8.3 Hz, 1H), 4.54 (q, J = 6.9 Hz, 2H), 1.55 (t, J = 7.0 Hz, 3H); 13C NMR (151 MHz, CDCl3) δ 165.1, 148.0, 140.7, 133.9, 133.0, 132.9, 132.8, 132.5, 131.6, 129.2, 129.2, 129.0, 128.1, 127.9, 127.7, 127.7, 126.5, 126.5, 125.5, 122.8, 122.4, 119.9, 115.1, 109.4, 103.1, 60.1, 14.6 (two carbon peaks are overlapped); IR (ATR): 3050, 2979, 1665, 1559, 1465, 1442 cm-1; HRMS (ESI) calcd for C29H21NO2 [M + H]+ 416.1645, found 416.1649.Mp = 162-164 DEG C; 1 H NMR (300 MHz, CDCl 3) δ 8.73 (d, J = 7.5 Hz, 1H), 8.20 (d, J = 7.9 Hz, 1H), 7.82 (dd, J = 18.3, 7.5 Hz, 3H), 7.70 (dd, J = 11.0, 8.3 Hz, 2H), 7.58-7.36 (m, 5H), 7.17-7.08 (m, J = 14.7, 7.4 Hz, 1H), 7.06 (s, 1H), 6.67 (t, J = 7.6 Hz, 1H), 6.13 (d, J = 8.3 Hz, 1H), 4.54 (q, J = 6.9 Hz, 2H), 1.55 (t, J = 7.0 Hz, 3H); 13 C NMR (151 MHz, CDCl 3) δ 165.1, 148.0, 140.7, 133.9, 133.0, 132.9, 132.8, 132.5, 131.6, 129.2, 129.2, 129.0, 128.1, 127.9, 127.7, 127.7, 126.5, 126.5, 125.5, 122.8 , 122.4, 119.9, 115.1, 109.4, 103.1, 60.1, 14.6 (two carbon peaks are overlapped); IR (ATR): 3050, 2979, 1665, 1559, 1465, 1442 cm < -1 & gt ;; HRMS (ESI) calcd for C 29 H 21 NO 2 [M + H] + 416.1645, found 416.1649.
실시예 13. 에틸 (Z)-6-벤질리덴-2-메톡시-6H-이소인돌로[2,1-a]인돌-11-카복실레이트의 합성Example 13. Synthesis of ethyl (Z) -6-benzylidene-2-methoxy-6H-isoindolo [2,1-a] indole-11-
반응시간 15분, 수율 94%, 노란색 고체Reaction time 15 min, yield 94%, yellow solid
M.p. = 131-133 ℃; 1H NMR (300 MHz, CDCl3) δ 8.64 (d, J = 7.4 Hz, 1H), 7.74-7.63 (m, 2H), 7.49-7.28 (m, 7H), 6.96 (s, 1H), 6.42 (d, J = 9.1 Hz, 1H), 5.86 (d, J = 9.1 Hz, 1H), 4.51 (q, J = 7.1 Hz, 2H), 3.84 (s, 3H), 1.54 (t, J = 7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 165.0, 155.5, 148.1, 140.2, 135.4, 133.8, 132.7, 129.9, 129.3, 129.1, 128.7, 128.5, 128.1, 127.3, 125.1, 119.8, 115.5, 111.6, 109.1, 104.5, 102.3, 60.0, 55.4, 14.6; IR (ATR): 3051, 2980, 2928, 2828, 1687, 1580, 1472, 1435 cm-1; HRMS (ESI) calcd for C26H21NO3 [M + H]+ 396.1594, found 396.1599.Mp = 131-133 [deg.] C; 1 H NMR (300 MHz, CDCl 3) δ 8.64 (d, J = 7.4 Hz, 1H), 7.74-7.63 (m, 2H), 7.49-7.28 (m, 7H), 6.96 (s, 1H), 6.42 ( d, J = 9.1 Hz, 1H ), 5.86 (d, J = 9.1 Hz, 1H), 4.51 (q, J = 7.1 Hz, 2H), 3.84 (s, 3H), 1.54 (t, J = 7.1 Hz, 3H); 13 C NMR (75 MHz, CDCl 3) δ 165.0, 155.5, 148.1, 140.2, 135.4, 133.8, 132.7, 129.9, 129.3, 129.1, 128.7, 128.5, 128.1, 127.3, 125.1, 119.8, 115.5, 111.6, 109.1, 104.5 , 102.3, 60.0, 55.4, 14.6; IR (ATR): 3051, 2980, 2928, 2828, 1687, 1580, 1472, 1435 cm -1 ; HRMS (ESI) calcd for C 26 H 21 NO 3 [M + H] + 396.1594, found 396.1599.
실시예 14. 에틸 (Z)-6-벤질리덴-2-(트리플루오로메틸)-6H-이소인돌로[2,1-a]인돌-11-카복실레이트의 합성Synthesis of ethyl (Z) -6-benzylidene-2- (trifluoromethyl) -6H-isoindolo [2,1-a] indole-11-carboxylate
반응시간 15분, 수율 98%, 연노란색 고체Reaction time 15 min, yield 98%, pale yellow solid
M.p. = 157-159 ℃; 1H NMR (300 MHz, CDCl3) δ 8.64 (d, J = 6.2 Hz, 1H), 8.42 (s, 1H), 7.64 (d, J = 6.0 Hz, 1H), 7.37 (t, J = 19.5 Hz, 7H), 7.00 (d, J = 11.0 Hz, 2H), 5.94 (d, J = 8.8 Hz, 1H), 4.49 (q, J = 7.0 Hz, 2H), 1.53 (t, J = 7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 164.5, 149.2, 140.2, 135.2, 133.7, 133.6, 131.1, 129.9, 129.5, 129.4, 128.7, 128.5, 128.5, 125.7, 124.8 (q, J F -C = 270 Hz), 124.4 (q, J F -C = 32.25 Hz), 120.0, 119.8 (q, J F -C = 4.5 Hz), 119.5 (q, J F -C = 3.0 Hz), 114.8, 110.4, 102.9, 60.4, 14.5; IR (ATR): 2986, 2926, 1683, 1614, 1562, 1447, 1422, 1325 cm-1; HRMS (ESI) calcd for C26H18F3NO2 [M + H]+ 434.1362, found 434.1360.Mp = 157-159 DEG C; 1 H NMR (300 MHz, CDCl 3) δ 8.64 (d, J = 6.2 Hz, 1H), 8.42 (s, 1H), 7.64 (d, J = 6.0 Hz, 1H), 7.37 (t, J = 19.5 Hz , 7H), 7.00 (d, J = 11.0 Hz, 2H), 5.94 (d, J = 8.8 Hz, 1H), 4.49 (q, J = 7.0 Hz, 2H), 1.53 (t, J = 7.1 Hz, 3H ); 13 C NMR (75 MHz, CDCl 3) δ 164.5, 149.2, 140.2, 135.2, 133.7, 133.6, 131.1, 129.9, 129.5, 129.4, 128.7, 128.5, 128.5, 125.7, 124.8 (q, J F -C = 270 Hz ), 124.4 (q, J F -C = 32.25 Hz), 120.0, 119.8 (q, J F -C = 4.5 Hz), 119.5 (q, J F -C = 3.0 Hz), 114.8, 110.4, 102.9, 60.4 , 14.5; IR (ATR): 2986, 2926, 1683, 1614, 1562, 1447, 1422, 1325 cm -1 ; HRMS (ESI) calcd for C 26 H 18 F 3 NO 2 [M + H] + 434.1362, found 434.1360.
실시예 15. 에틸 (Z)-6-벤질리덴-8-메톡시-6H-이소인돌로[2,1-a]인돌-11-카복실레이트의 합성Example 15. Synthesis of ethyl (Z) -6-benzylidene-8-methoxy-6H-isoindolo [2,1-a] indole-11-
반응시간 10분, 수율 98%, 노란색 고체Reaction time 10 min, yield 98%, yellow solid
M.p. = 120-127 ℃; 1H NMR (300 MHz, CDCl3) δ 8.56 (d, J = 8.6 Hz, 1H), 8.15 (d, J = 7.9 Hz, 1H), 7.36 (dd, J = 13.1, 3.8 Hz, 5H), 7.18-7.06 (m, 2H), 6.95 (d, J = 8.6 Hz, 1H), 6.88 (s, 1H), 6.80 (t, J = 7.7 Hz, 1H), 5.96 (d, J = 8.3 Hz, 1H), 4.50 (q, J = 7.1 Hz, 2H), 3.88 (s, 3H), 1.53 (t, J = 7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 165.3, 160.7, 148.5, 142.5, 135.4, 133.8, 132.5, 131.6, 130.1, 128.4, 128.1, 126.6, 122.4, 122.3, 122.2, 115.6, 114.8, 109.2, 104.8, 101.5, 60.0, 55.6, 14.7 (one carbon peak is overlapped); IR (ATR): 3048, 2987, 2835, 1667, 1562, 1436, 1163 cm-1; HRMS (ESI) calcd for C26H21NO3 [M + H]+ 396.1594, found 396.1592.Mp = 120-127 DEG C; 1 H NMR (300 MHz, CDCl 3) δ 8.56 (d, J = 8.6 Hz, 1H), 8.15 (d, J = 7.9 Hz, 1H), 7.36 (dd, J = 13.1, 3.8 Hz, 5H), 7.18 -7.06 (m, 2H), 6.95 (d, J = 8.6 Hz, 1H), 6.88 (s, 1H), 6.80 (t, J = 7.7 Hz, 1H), 5.96 (d, J = 8.3 Hz, 1H) , 4.50 (q, J = 7.1 Hz, 2H), 3.88 (s, 3H), 1.53 (t, J = 7.1 Hz, 3H); 13 C NMR (75 MHz, CDCl 3) δ 165.3, 160.7, 148.5, 142.5, 135.4, 133.8, 132.5, 131.6, 130.1, 128.4, 128.1, 126.6, 122.4, 122.3, 122.2, 115.6, 114.8, 109.2, 104.8, 101.5 , 60.0, 55.6, 14.7 (one carbon peak is overlapped); IR (ATR): 3048, 2987, 2835, 1667, 1562, 1436, 1163 cm < -1 & gt ;; HRMS (ESI) calcd for C 26 H 21 NO 3 [M + H] + 396.1594, found 396.1592.
실시예 16. 에틸 (Z)-6-벤질리덴-8-브로모-6H-이소인돌로[2,1-a]인돌-11-카복실레이트의 합성Example 16. Synthesis of ethyl (Z) -6-benzylidene-8-bromo-6H-isoindolo [2,1-a] indole-11-
실시예 1과 동일한 방법으로 수행하되, 10 mol% Pd(OAc)2 및 20 mol% PPh3를 사용하였다. The procedure of Example 1 was repeated except that 10 mol% Pd (OAc) 2 and 20 mol% PPh 3 were used.
반응시간 30분, 수율 92%, 노란색 고체Reaction time 30 min, yield 92%, yellow solid
M.p. = 134-140 ℃; 1H NMR (300 MHz, CDCl3) δ 8.50 (d, J = 8.3 Hz, 1H), 8.14 (d, J = 7.9 Hz, 1H), 7.75 (s, 1H), 7.50 (t, J = 9.8 Hz, 1H), 7.42-7.27 (m, 5H), 7.14 (t, J = 7.6 Hz, 1H), 6.89 (s, 1H), 6.82 (t, J = 7.7 Hz, 1H), 5.96 (d, J = 8.3 Hz, 1H), 4.47 (q, J = 7.1 Hz, 2H), 1.51 (t, J = 7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 164.9, 146.8, 141.9, 134.9, 132.6, 132.2, 132.0, 131.3, 130.0, 128.4, 128.3, 127.7, 126.6, 123.1, 123.0, 123.0, 122.6, 122.4, 115.0, 110.2, 103.1, 60.2, 14.6; IR (ATR): 3047, 2983, 1689, 1577, 1557, 1440 cm-1; HRMS (ESI) calcd for C25H18BrNO2 [M + H]+ 444.0594, found 444.0591.Mp = 134-140 DEG C; 1 H NMR (300 MHz, CDCl 3) δ 8.50 (d, J = 8.3 Hz, 1H), 8.14 (d, J = 7.9 Hz, 1H), 7.75 (s, 1H), 7.50 (t, J = 9.8 Hz J = 7.6 Hz, 1 H), 6.82 (t, J = 7.7 Hz, 1 H), 5.96 (d, J = 8.3 Hz, 1H), 4.47 (q, J = 7.1 Hz, 2H), 1.51 (t, J = 7.1 Hz, 3H); 13 C NMR (75 MHz, CDCl 3) δ 164.9, 146.8, 141.9, 134.9, 132.6, 132.2, 132.0, 131.3, 130.0, 128.4, 128.3, 127.7, 126.6, 123.1, 123.0, 123.0, 122.6, 122.4, 115.0, 110.2 , 103.1, 60.2, 14.6; IR (ATR): 3047, 2983, 1689, 1577, 1557, 1440 cm < -1 & gt ;; HRMS (ESI) calcd for C 25 H 18 BrNO 2 [M + H] + 444.0594, found 444.0591.
실시예 17. 에틸 5-페닐인돌로[2,1-a]이소퀴놀린-12-카복실레이트의 합성Example 17. Synthesis of ethyl 5-phenylindolo [2,1-a] isoquinoline-12-carboxylate
인돌 아인아마이드인 에틸 2-페닐-1-(페닐에티닐)-1H-인돌-3-카복실레이트, (73.1 mg, 0.2 mmol), PtCl2 (5.3 mg, 0.02 mmol)와 톨루엔 (1 mL)를 캡이 달린 바이알에 넣었다. 반응 혼합물을 알루미늄 블록 안에서 110 ℃로 교반하면서 1H NMR 상에서 출발물질이 없어지는 것이 확인될 때까지(~16시간) 반응시켰다. 실온으로 냉각한 후, 반응 혼합물을 규조토에 CH2Cl2를 이용하여 세척한 뒤, 여과하고 진공에서 농축하였다. 실리카겔 컬럼크로마토그래피법을 이용하여 정제하였다. 분리가 되지 않는 α-클로로엔아민(α-chloroenamine)은 원심분리기를 이용하여 헥산에 배산한 뒤, 경사분리하여 제거하였다. 모은 상등액을 농축한 뒤, 진공에서 건조하였다. 잔여물은 헥산에서 결정화하여 추가적으로 정제된 화합물을 얻었으며, 합산하여 수율을 계산하였다. (73.1 mg, 0.2 mmol), PtCl 2 (5.3 mg, 0.02 mmol) and toluene (1 mL) were added to a solution of ethyl 2-phenyl-1- (phenylethynyl) I put it in a capped vial. The reaction mixture was stirred in an aluminum block at 110 < 0 > C until reaction was confirmed to be complete (~ 16 hours) by 1 H NMR. After cooling to room temperature, the reaction mixture was washed with diatomaceous earth with CH 2 Cl 2 , then filtered and concentrated in vacuo. And purified by silica gel column chromatography. The non-separable α-chloroenamine was removed by decantation on a centrifuge using hexane and then decanted. The combined supernatant was concentrated and dried in vacuo. The residue was crystallized from hexane to give further purified compound which was summed to yield.
수율 59%, 연노란색 고체Yield 59%, pale yellow solid
M.p. = 177-178 ℃; 1H NMR (300 MHz, CDCl3) δ 9.88 (d, J = 8.3 Hz, 1H), 8.40 (d, J = 8.1 Hz, 1H), 8.14 (s, 1H), 7.78 (d, J = 8.1 Hz, 1H), 7.65 (dd, J = 14.5, 8.0 Hz, 2H), 7.59-7.42 (m, 7H), 7.37 (t, J = 7.6 Hz, 1H), 4.59 (q, J = 7.0 Hz, 2H), 1.59 (t, J = 7.0 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 166.4, 137.2, 136.5, 131.0, 130.8, 130.2, 129.1, 128.9, 128.6, 128.5, 128.0, 127.3, 125.4, 125.2, 125.0, 124.2, 122.5, 122.1, 120.4, 109.6, 100.8, 60.2, 14.6; IR (ATR): 3049, 2974, 1668, 1598, 1491, 1448, 1365 cm-1; HRMS (ESI) calcd for C25H19NO2 [M + H]+ 366.1489, found 366.1489.Mp = 177-178 [deg.] C; 1 H NMR (300 MHz, CDCl 3) δ 9.88 (d, J = 8.3 Hz, 1H), 8.40 (d, J = 8.1 Hz, 1H), 8.14 (s, 1H), 7.78 (d, J = 8.1 Hz , 1H), 7.65 (dd, J = 14.5, 8.0 Hz, 2H), 7.59-7.42 (m, 7H), 7.37 (t, J = 7.6 Hz, 1H), 4.59 (q, J = 7.0 Hz, 2H) , 1.59 (t, J = 7.0 Hz, 3 H); 13 C NMR (75 MHz, CDCl 3) δ 166.4, 137.2, 136.5, 131.0, 130.8, 130.2, 129.1, 128.9, 128.6, 128.5, 128.0, 127.3, 125.4, 125.2, 125.0, 124.2, 122.5, 122.1, 120.4, 109.6 , 100.8, 60.2, 14.6; IR (ATR): 3049, 2974, 1668, 1598, 1491, 1448, 1365 cm < -1 & gt ;; HRMS (ESI) calcd for C 25 H 19 NO 2 [M + H] + 366.1489, found 366.1489.
실시예 18. 에틸 5-(p-톨릴)인돌로[2,1-a]이소퀴놀린-12-카복실레이트의 합성Example 18. Synthesis of ethyl 5- (p-tolyl) indolo [2,1-a] isoquinoline-12-carboxylate
수율 53%, 연노란색 고체Yield 53%, pale yellow solid
M.p. = 171-172 ℃; 1H NMR (300 MHz, CDCl3) δ 9.87 (d, J = 8.3 Hz, 1H), 8.40 (d, J = 8.1 Hz, 1H), 8.15 (s, 1H), 7.80 (d, J = 8.1 Hz, 1H), 7.66 (dd, J = 20.0, 8.0 Hz, 2H), 7.59-7.28 (m, 7H), 4.59 (q, J = 13.6, 6.6 Hz, 2H), 2.49 (s, 3H), 1.59 (t, J = 6.6 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 166.5, 137.9, 137.3, 133.5, 131.2, 130.8, 130.0, 129.3, 129.1, 128.8, 128.5, 127.3, 125.5, 125.2, 125.0, 124.2, 122.5, 122.2, 120.3, 109.6, 100.7, 60.3, 21.3, 14.6; IR (ATR): 3080, 3023, 2899, 1670, 1495, 1452, 1365 cm-1; HRMS (ESI) calcd for C26H21NO2 [M + H]+ 380.1645, found 380.1643.Mp = 171-172 DEG C; 1 H NMR (300 MHz, CDCl 3) δ 9.87 (d, J = 8.3 Hz, 1H), 8.40 (d, J = 8.1 Hz, 1H), 8.15 (s, 1H), 7.80 (d, J = 8.1 Hz , 1H), 7.66 (dd, J = 20.0, 8.0 Hz, 2H), 7.59-7.28 (m, 7H), 4.59 (q, J = 13.6, 6.6 Hz, 2H), 2.49 (s, 3H), 1.59 ( t, J = 6.6 Hz, 3H); 13 C NMR (75 MHz, CDCl 3) δ 166.5, 137.9, 137.3, 133.5, 131.2, 130.8, 130.0, 129.3, 129.1, 128.8, 128.5, 127.3, 125.5, 125.2, 125.0, 124.2, 122.5, 122.2, 120.3, 109.6 , 100.7, 60.3, 21.3, 14.6; IR (ATR): 3080, 3023, 2899, 1670, 1495, 1452, 1365 cm -1 ; HRMS (ESI) calcd for C 26 H 21 NO 2 [M + H] + 380.1645, found 380.1643.
실시예 19. 에틸 5-(4-(메톡시카보닐)페닐)인돌로[2,1-a]이소퀴놀린-12-카복실레이트의 합성Example 19. Synthesis of ethyl 5- (4- (methoxycarbonyl) phenyl) indolo [2,1-a] isoquinoline-12-carboxylate
수율 65%, 고체Yield 65%, solid
M.p. = 182-187 ℃; 1H NMR (300 MHz, CDCl3) δ 9.83 (d, J = 7.7 Hz, 1H), 8.36 (d, J = 8.0 Hz, 1H), 8.19 (d, J = 8.1 Hz, 2H), 8.12 (s, 1H), 7.78 (d, J = 8.1 Hz, 1H), 7.67-7.41 (m, 6H), 7.36 (t, J = 7.5 Hz, 1H), 4.57 (q, J = 7.1 Hz, 2H), 3.98 (s, 3H), 1.57 (t, J = 7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 166.7, 166.3, 141.3, 137.1, 130.7, 130.3, 130.2, 129.9, 129.6, 129.2, 128.9, 128.5, 127.5, 125.2, 125.0, 124.3, 123.9, 122.5, 122.3, 120.6, 109.56, 101.1, 60.3, 52.3, 14.6; IR (ATR): 3075, 2923, 2852, 1714, 1677, 1601, 1492, 1452 cm-1; HRMS (ESI) calcd for C27H21NO4 [M + H]+ 424.1543, found 424.1541.Mp = 182-187 [deg.] C; 1 H NMR (300 MHz, CDCl 3) δ 9.83 (d, J = 7.7 Hz, 1H), 8.36 (d, J = 8.0 Hz, 1H), 8.19 (d, J = 8.1 Hz, 2H), 8.12 (s , 1H), 7.78 (d, J = 8.1 Hz, 1H), 7.67-7.41 (m, 6H), 7.36 (t, J = 7.5 Hz, 1H), 4.57 (q, J = 7.1 Hz, 2H), 3.98 (s, 3H), 1.57 (t, J = 7.1 Hz, 3H); 13 C NMR (75 MHz, CDCl 3) δ 166.7, 166.3, 141.3, 137.1, 130.7, 130.3, 130.2, 129.9, 129.6, 129.2, 128.9, 128.5, 127.5, 125.2, 125.0, 124.3, 123.9, 122.5, 122.3, 120.6 , 109.56, 101.1, 60.3, 52.3, 14.6; IR (ATR): 3075, 2923, 2852, 1714, 1677, 1601, 1492, 1452 cm -1 ; HRMS (ESI) calcd for C 27 H 21 NO 4 [M + H] + 424.1543, found 424.1541.
실시예 20. 에틸 5-(4-포밀페닐)인돌로[2,1-a]이소퀴놀린-12-카복실레이트의 합성Example 20. Synthesis of ethyl 5- (4-formylphenyl) indolo [2,1-a] isoquinoline-12-carboxylate
수율 58%, 연노란색 고체Yield 58%, pale yellow solid
M.p. = 228-231 ℃; 1H NMR (300 MHz, CDCl3) δ 10.11 (s, 1H), 9.83 (d, J = 8.1 Hz, 1H), 8.37 (d, J = 8.0 Hz, 1H), 8.14 (s, 1H), 8.03 (d, J = 7.7 Hz, 2H), 7.79 (d, J = 8.1 Hz, 1H), 7.73-7.65 (m, 2H), 7.64-7.30 (m, 5H), 4.57 (q, J = 7.0 Hz, 2H), 1.57 (t, J = 7.0 Hz, 3H); 13C NMR (151 MHz, CDCl3) δ 191.6, 166.4, 143.1, 137.1, 135.9, 130.9, 130.8, 130.2, 130.0, 129.3, 129.1, 128.6, 127.7, 125.4, 125.0, 124.5, 123.9, 122.7, 122.5, 120.8, 109.5, 101.5, 60.4, 14.6; IR (ATR): 3050, 2973, 2900, 2841, 1672, 1601, 1489, 1452 cm-1; HRMS (ESI) calcd for C26H19NO3 [M + H]+ 394.1438, found 394.1433.Mp = 228-231 DEG C; 1 H NMR (300 MHz, CDCl 3) δ 10.11 (s, 1H), 9.83 (d, J = 8.1 Hz, 1H), 8.37 (d, J = 8.0 Hz, 1H), 8.14 (s, 1H), 8.03 (d, J = 7.7 Hz, 2H), 7.79 (d, J = 8.1 Hz, 1H), 7.73-7.65 (m, 2H), 7.64-7.30 (m, 5H), 4.57 (q, J = 7.0 Hz, 2H), 1.57 (t, J = 7.0 Hz, 3 H); 13 C NMR (151 MHz, CDCl 3) δ 191.6, 166.4, 143.1, 137.1, 135.9, 130.9, 130.8, 130.2, 130.0, 129.3, 129.1, 128.6, 127.7, 125.4, 125.0, 124.5, 123.9, 122.7, 122.5, 120.8 , 109.5, 101.5, 60.4, 14.6; IR (ATR): 3050, 2973, 2900, 2841, 1672, 1601, 1489, 1452 cm -1 ; HRMS (ESI) calcd for C 26 H 19 NO 3 [M + H] + 394.1438, found 394.1433.
실시예 21. 에틸 5-(4-(트리플루오로메틸)페닐)인돌로[2,1-a]이소퀴놀린-12-카복실레이트의 합성Example 21. Synthesis of ethyl 5- (4- (trifluoromethyl) phenyl) indolo [2,1-a] isoquinoline-12-carboxylate
수율 62%, 연노란색 고체Yield 62%, pale yellow solid
M.p. = 196-199 ℃; 1H NMR (300 MHz, CDCl3) δ 9.84 (d, J = 8.2 Hz, 1H), 8.37 (d, J = 8.0 Hz, 1H), 8.11 (s, 1H), 7.78 (t, J = 9.8 Hz, 3H), 7.71-7.42 (m, 6H), 7.37 (t, J = 7.3 Hz, 1H), 4.57 (q, J = 7.0 Hz, 2H), 1.58 (t, J = 7.0 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 166.4, 140.3, 137.0, 130.7, 130.5, 130.3, 130.2 (q, J F -C = 32.25 Hz), 129.3, 128.9, 128.4, 127.6, 125.7 (q, J F -C = 3.75 Hz), 125.2, 125.0, 124.4, 124.1 (q, J F -C = 270.75 Hz), 123.6, 122.6, 122.4, 120.7, 109.5, 101.2, 60.3, 14.6; IR (ATR): 3067, 2982, 2924, 2849, 1698, 1615, 1494, 1452, 1318 cm-1; HRMS (ESI) calcd for C26H18F3NO2 [M + H]+ 434.1362, found 434.1360.Mp = 196-199 DEG C; 1 H NMR (300 MHz, CDCl 3) δ 9.84 (d, J = 8.2 Hz, 1H), 8.37 (d, J = 8.0 Hz, 1H), 8.11 (s, 1H), 7.78 (t, J = 9.8 Hz , 3H), 7.71-7.42 (m, 6H), 7.37 (t, J = 7.3 Hz, 1H), 4.57 (q, J = 7.0 Hz, 2H), 1.58 (t, J = 7.0 Hz, 3H); 13 C NMR (75 MHz, CDCl 3) δ 166.4, 140.3, 137.0, 130.7, 130.5, 130.3, 130.2 (q, J F -C = 32.25 Hz), 129.3, 128.9, 128.4, 127.6, 125.7 (q, J F -C = 3.75 Hz), 125.2, 125.0, 124.4, 124.1 (q, J F = -C = 270.75 Hz), 123.6, 122.6, 122.4, 120.7, 109.5, 101.2, 60.3, 14.6; IR (ATR): 3067, 2982, 2924, 2849, 1698, 1615, 1494, 1452, 1318 cm- 1 ; HRMS (ESI) calcd for C 26 H 18 F 3 NO 2 [M + H] + 434.1362, found 434.1360.
실시예 22. 에틸 5-(4-플루오로페닐)인돌로[2,1-a]이소퀴놀린-12-카복실레이트의 합성Example 22. Synthesis of ethyl 5- (4-fluorophenyl) indolo [2,1-a] isoquinoline-12-carboxylate
수율 67%, 노란색 고체Yield 67%, yellow solid
M.p. = 192-193 ℃; 1H NMR (300 MHz, CDCl3) δ 9.86 (d, J = 8.2 Hz, 1H), 8.39 (d, J = 8.1 Hz, 1H), 8.11 (s, 1H), 7.79 (d, J = 8.2 Hz, 1H), 7.69-7.42 (m, 6H), 7.38 (t, J = 7.5 Hz, 1H), 7.23 (t, J = 8.5 Hz, 2H), 4.58 (q, J = 7.1 Hz, 2H), 1.58 (t, J = 7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 166.4, 162.6 (d, J F -C = 246.0 Hz), 137.2, 132.5, 132.5 (d, J F -C = 3.3 Hz), 131.8 (d, J F -C = 8.2 Hz), 130.9, 130.8, 129.2, 128.9, 128.5, 127.4, 125.2, 124.3, 123.9, 122.5, 122.2, 120.5, 115.7 (d, J F -C = 21.75 Hz), 109.5, 100.9, 60.3, 14.6; IR (ATR): 3053, 2974, 2899, 1664, 1493, 1448, 1363 cm-1; HRMS (ESI) calcd for C25H18FNO2 [M + H]+ 384.1394, found 384.1392.Mp = 192-193 DEG C; 1 H NMR (300 MHz, CDCl 3) δ 9.86 (d, J = 8.2 Hz, 1H), 8.39 (d, J = 8.1 Hz, 1H), 8.11 (s, 1H), 7.79 (d, J = 8.2 Hz , 1H), 7.69-7.42 (m, 6H), 7.38 (t, J = 7.5 Hz, 1H), 7.23 (t, J = 8.5 Hz, 2H), 4.58 (q, J = 7.1 Hz, 2H), 1.58 (t, J = 7.1 Hz, 3 H); 13 C NMR (75 MHz, CDCl 3) δ 166.4, 162.6 (d, J F -C = 246.0 Hz), 137.2, 132.5 , 132.5 (d, J F -C = 3.3 Hz), 131.8 (d , J F -C = 8.2 Hz), 130.9, 130.8 , 129.2, 128.9, 128.5, 127.4, 125.2, 124.3, 123.9, 122.5, 122.2, 120.5, 115.7 (d, J F -C = 21.75 Hz), 109.5, 100.9, 60.3, 14.6; IR (ATR): 3053, 2974, 2899, 1664, 1493, 1448, 1363 cm -1 ; HRMS (ESI) calcd for C 25 H 18 FNO 2 [M + H] + 384.1394, found 384.1392.
실시예 23. 에틸 5-(o-톨릴)인돌로[2,1-a]이소퀴놀린-12-카복실레이트의 합성Example 23. Synthesis of ethyl 5- (o-tolyl) indolo [2,1-a] isoquinoline-12-carboxylate
수율 50%, 연노란색 고체Yield 50%, pale yellow solid
M.p. = 88-90 ℃; 1H NMR (300 MHz, CDCl3) δ 9.91 (d, J = 8.3 Hz, 1H), 8.45 (d, J = 8.1 Hz, 1H), 8.16 (s, 1H), 7.80 (d, J = 8.2 Hz, 1H), 7.66 (t, J = 7.6 Hz, 2H), 7.58-7.33 (m, 7H), 7.33-7.24 (m, 1H), 4.62 (dd, J = 14.2, 7.1 Hz, 2H), 2.16 (s, 3H), 1.61 (t, J = 7.1 Hz, 3H); 13C NMR (151 MHz, CDCl3) δ 166.5, 137.9, 137.5, 135.8, 131.2, 130.9, 130.9, 130.2, 129.3, 128.9, 128.6, 128.5, 127.3, 126.1, 125.4, 125.1, 124.3, 124.2, 122.6, 122.2, 120.4, 109.6, 101.0, 60.2, 20.0, 14.6; IR (ATR): 3050, 2975, 1682, 1488, 1452, 1355 cm-1; HRMS (ESI) calcd for C26H21NO2 [M + H]+ 380.1645, found 380.1641.Mp = 88-90 DEG C; 1 H NMR (300 MHz, CDCl 3) δ 9.91 (d, J = 8.3 Hz, 1H), 8.45 (d, J = 8.1 Hz, 1H), 8.16 (s, 1H), 7.80 (d, J = 8.2 Hz , 1H), 7.66 (t, J = 7.6 Hz, 2H), 7.58-7.33 (m, 7H), 7.33-7.24 (m, 1H), 4.62 (dd, J = 14.2, 7.1 Hz, 2H), 2.16 ( s, 3H), 1.61 (t, J = 7.1 Hz, 3H); 13 C NMR (151 MHz, CDCl 3) δ 166.5, 137.9, 137.5, 135.8, 131.2, 130.9, 130.9, 130.2, 129.3, 128.9, 128.6, 128.5, 127.3, 126.1, 125.4, 125.1, 124.3, 124.2, 122.6, 122.2 , 120.4, 109.6, 101.0, 60.2, 20.0, 14.6; IR (ATR): 3050, 2975, 1682, 1488, 1452, 1355 cm < -1 & gt ;; HRMS (ESI) calcd for C 26 H 21 NO 2 [M + H] + 380.1645, found 380.1641.
실시예 24. 에틸 5-(3-메톡시페닐)인돌로[2,1-a]이소퀴놀린-12-카복실레이트의 합성Example 24. Synthesis of ethyl 5- (3-methoxyphenyl) indolo [2,1-a] isoquinoline-12-carboxylate
수율 57%, 연노란색 고체Yield 57%, pale yellow solid
M.p. = 142-145 ℃; 1H NMR (300 MHz, CDCl3) δ 9.87 (d, J = 8.2 Hz, 1H), 8.40 (d, J = 8.0 Hz, 1H), 8.17 (s, 1H), 7.80 (d, J = 8.2 Hz, 1H), 7.71 (d, J = 8.0 Hz, 1H), 7.63 (dd, J = 11.2, 4.2 Hz, 1H), 7.59-7.51 (m, 1H), 7.50-7.33 (m, 3H), 7.16-6.98 (m, 3H), 4.59 (q, J = 7.1 Hz, 2H), 3.88 (s, 3H), 1.58 (t, J = 7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 166.4, 159.7, 137.9, 137.3, 130.9, 130.8, 129.7, 129.2, 128.9, 128.5, 127.3, 125.4, 125.2, 124.9, 124.2, 122.6, 122.5, 122.2, 120.3, 115.8, 113.4, 109.6, 100.9, 60.3, 55.3, 14.6; IR (ATR): 3022, 2976, 2933, 1675, 1581, 1488, 1457, 1362 cm-1; HRMS (ESI) calcd for C26H21NO3 [M + H]+ 396.1594, found 396.1592.Mp = 142-145 [deg.] C; 1 H NMR (300 MHz, CDCl 3) δ 9.87 (d, J = 8.2 Hz, 1H), 8.40 (d, J = 8.0 Hz, 1H), 8.17 (s, 1H), 7.80 (d, J = 8.2 Hz 1H), 7.71 (d, J = 8.0 Hz, 1H), 7.63 (dd, J = 11.2, 4.2 Hz, 1H), 7.59-7.51 (m, 1H), 7.50-7.33 6.98 (m, 3H), 4.59 (q, J = 7.1 Hz, 2H), 3.88 (s, 3H), 1.58 (t, J = 7.1 Hz, 3H); 13 C NMR (75 MHz, CDCl 3) δ 166.4, 159.7, 137.9, 137.3, 130.9, 130.8, 129.7, 129.2, 128.9, 128.5, 127.3, 125.4, 125.2, 124.9, 124.2, 122.6, 122.5, 122.2, 120.3, 115.8 , 113.4, 109.6, 100.9, 60.3, 55.3, 14.6; IR (ATR): 3022, 2976, 2933, 1675, 1581, 1488, 1457, 1362 cm < -1 & gt ;; HRMS (ESI) calcd for C 26 H 21 NO 3 [M + H] + 396.1594, found 396.1592.
실시예 25. 에틸 5-(3-클로로페닐)인돌로[2,1-a]이소퀴놀린-12-카복실레이트의 합성Example 25. Synthesis of ethyl 5- (3-chlorophenyl) indolo [2,1-a] isoquinoline-12-carboxylate
수율 58%, 연노란색 고체Yield 58%, pale yellow solid
M.p. = 179-182 ℃; 1H NMR (300 MHz, CDCl3) δ 9.84 (d, J = 8.1 Hz, 1H), 8.38 (d, J = 8.1 Hz, 1H), 8.10 (s, 1H), 7.77 (d, J = 8.2 Hz, 1H), 7.68-7.28 (m, 9H), 4.57 (q, J = 7.1 Hz, 2H), 1.58 (t, J = 7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 166.3, 138.4, 137.1, 134.5, 130.8, 130.4, 130.1, 129.9, 129.2, 128.9, 128.5, 128.4, 128.2, 127.5, 125.2, 125.1, 124.3, 123.6, 122.6, 122.3, 120.6, 109.5, 101.1, 60.3, 14.6; IR (ATR): 3050, 2974, 1690, 1634, 1505, 1452 cm-1; HRMS (ESI) calcd for C25H18ClNO2 [M + H]+ 400.1099, found 400.1099.Mp = 179-182 DEG C; 1 H NMR (300 MHz, CDCl 3) δ 9.84 (d, J = 8.1 Hz, 1H), 8.38 (d, J = 8.1 Hz, 1H), 8.10 (s, 1H), 7.77 (d, J = 8.2 Hz , 1H), 7.68-7.28 (m, 9H), 4.57 (q, J = 7.1 Hz, 2H), 1.58 (t, J = 7.1 Hz, 3H); 13 C NMR (75 MHz, CDCl 3) δ 166.3, 138.4, 137.1, 134.5, 130.8, 130.4, 130.1, 129.9, 129.2, 128.9, 128.5, 128.4, 128.2, 127.5, 125.2, 125.1, 124.3, 123.6, 122.6, 122.3 , 120.6, 109.5, 101.1, 60.3, 14.6; IR (ATR): 3050, 2974, 1690, 1634, 1505, 1452 cm < -1 & gt ;; HRMS (ESI) calcd for C 25 H 18 ClNO 2 [M + H] + 400.1099, found 400.1099.
실시예 26. 에틸 5-헥실인돌로[2,1-a]이소퀴놀린-12-카복실레이트의 합성Example 26. Synthesis of ethyl 5-hexylindolo [2,1-a] isoquinoline-12-carboxylate
수율 54%, 연노란색 고체Yield 54%, pale yellow solid
M.p. = 89-91 ℃; 1H NMR (300 MHz, CDCl3) δ 9.89-9.77 (m, 1H), 8.36 (d, J = 7.9 Hz, 1H), 7.97 (s, 1H), 7.84-7.69 (m, 2H), 7.68-7.53 (m, 2H), 7.44 (t, J = 7.5 Hz, 1H), 7.40-7.30 (m, 1H), 4.56 (q, J = 7.1 Hz, 2H), 2.91-2.74 (m, 2H), 1.72 (dd, J = 14.2, 7.0 Hz, 2H), 1.62-1.50 (m, 3H), 1.51-1.21 (m, 6H), 0.91 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 166.5, 137.5, 131.1, 130.6, 129.1, 129.1, 128.4, 126.9, 125.4, 124.0, 123.1, 122.5, 122.2, 121.8, 118.9, 109.5, 100.2, 60.1, 31.7, 30.3, 29.3, 29.3, 22.6, 14.6, 14.1; IR (ATR): 3070, 2953, 2927, 2853, 1682, 1486, 1452, 1366 cm-1; HRMS (ESI) calcd for C25H27NO2 [M + H]+ 374.2115, found 374.2112.Mp = 89-91 DEG C; 1 H NMR (300 MHz, CDCl 3 )? 9.89-9.77 (m, 1 H), 8.36 (d, J = 7.9 Hz, 1 H), 7.97 J = 7.1 Hz, 2H), 2.91-2.74 (m, 2H), 1.72 (m, 2H), 7.44 (t, J = 7.5 Hz, 1H), 7.40-7.30 (dd, J = 14.2, 7.0 Hz, 2H), 1.62-1.50 (m, 3H), 1.51-1.21 (m, 6H), 0.91 (s, 3H); 13 C NMR (75 MHz, CDCl 3) δ 166.5, 137.5, 131.1, 130.6, 129.1, 129.1, 128.4, 126.9, 125.4, 124.0, 123.1, 122.5, 122.2, 121.8, 118.9, 109.5, 100.2, 60.1, 31.7, 30.3 , 29.3, 29.3, 22.6, 14.6, 14.1; IR (ATR): 3070, 2953, 2927, 2853, 1682, 1486, 1452, 1366 cm < -1 & gt ;; HRMS (ESI) calcd for C 25 H 27 NO 2 [M + H] + 374.2115, found 374.2112.
실시예 27. 에틸 5-(티오펜-2-yl)인돌로[2,1-a]이소퀴놀린-12-카복실레이트의 합성Example 27. Synthesis of ethyl 5- (thiophen-2-yl) indolo [2,1-a] isoquinoline-12-carboxylate
수율 22%, 연노란색 고체Yield 22%, pale yellow solid
M.p. = 168-169 ℃; 1H NMR (300 MHz, CDCl3) δ 9.83 (d, J = 7.9 Hz, 1H), 8.37 (d, J = 8.0 Hz, 1H), 8.28 (s, 1H), 7.97-7.88 (m, 1H), 7.80 (d, J = 8.1 Hz, 1H), 7.70-7.53 (m, 2H), 7.47 (t, J = 7.2 Hz, 2H), 7.38 (t, J = 7.2 Hz, 1H), 7.31-7.17 (m, 2H), 4.57 (q, J = 7.1 Hz, 2H), 1.57 (t, J = 7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 166.4, 137.2, 137.1, 130.9, 130.8, 129.3, 128.8, 128.5, 128.4, 127.5, 127.5, 126.2, 125.2, 125.1, 124.4, 122.6, 122.4, 121.7, 117.6, 109.6, 101.3, 60.3, 14.6; IR (ATR): 3064, 2971, 2891, 1676, 1497, 1453, 1367 cm-1; HRMS (ESI) calcd for C23H17NO2S [M + H]+ 372.1053, found 372.1051.Mp = 168-169 DEG C; 1 H NMR (300 MHz, CDCl 3) δ 9.83 (d, J = 7.9 Hz, 1H), 8.37 (d, J = 8.0 Hz, 1H), 8.28 (s, 1H), 7.97-7.88 (m, 1H) , 7.80 (d, J = 8.1 Hz, 1H), 7.70-7.53 (m, 2H), 7.47 (t, J = 7.2 Hz, 2H), 7.38 (t, J = 7.2 Hz, 1H), 7.31-7.17 m, 2H), 4.57 (q, J = 7.1 Hz, 2H), 1.57 (t, J = 7.1 Hz, 3H); 13 C NMR (75 MHz, CDCl 3) δ 166.4, 137.2, 137.1, 130.9, 130.8, 129.3, 128.8, 128.5, 128.4, 127.5, 127.5, 126.2, 125.2, 125.1, 124.4, 122.6, 122.4, 121.7, 117.6, 109.6 , 101.3, 60.3, 14.6; IR (ATR): 3064, 2971, 2891, 1676, 1497, 1453, 1367 cm < -1 & gt ;; HRMS (ESI) calcd for C 23 H 17 NO 2 S [M + H] + 372.1053, found 372.1051.
실시예 28. 에틸 5-(나프탈렌-2-일)인돌로[2,1-a]이소퀴놀린-12-카복실레이트의 합성Example 28. Synthesis of ethyl 5- (naphthalen-2-yl) indolo [2,1-a] isoquinoline-12-carboxylate
수율 75%, 연노란색 고체Yield 75%, pale yellow solid
M.p. = 212-213 ℃; 1H NMR (300 MHz, CDCl3) δ 9.92 (d, J = 8.3 Hz, 1H), 8.40 (t, J = 10.7 Hz, 1H), 8.20 (s, 1H), 8.04-7.86 (m, 4H), 7.77 (d, J = 8.2 Hz, 1H), 7.73-7.43 (m, 7H), 7.37 (t, J = 7.6 Hz, 1H), 4.61 (q, J = 7.1 Hz, 2H), 1.61 (t, J = 7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 166.5, 13.3, 134.1, 133.4, 132.8, 131.1, 130.9, 129.2, 129.0, 128.9, 128.6, 128.2, 128.1, 128.0, 127.8, 127.4, 126.6, 126.5, 125.5, 125.3, 125.0, 124.3, 122.6, 122.3, 120.7, 109.7, 101.0, 60.4, 14.7; IR (ATR): 3047, 2973, 2897, 1667, 1492, 1452 cm-1; HRMS (ESI) calcd for C29H21NO2 [M + H]+ 416.1645, found 416.1646. Mp = 212-213 [deg.] C; 1 H NMR (300 MHz, CDCl 3 )? 9.92 (d, J = 8.3 Hz, IH), 8.40 (t, J = 10.7 Hz, IH), 8.20 (s, IH), 8.04-7.86 , 7.77 (d, J = 8.2 Hz, 1H), 7.73-7.43 (m, 7H), 7.37 (t, J = 7.6 Hz, 1H), 4.61 (q, J = 7.1 Hz, 2H), 1.61 (t, J = 7.1 Hz, 3H); 13 C NMR (75 MHz, CDCl 3) δ 166.5, 13.3, 134.1, 133.4, 132.8, 131.1, 130.9, 129.2, 129.0, 128.9, 128.6, 128.2, 128.1, 128.0, 127.8, 127.4, 126.6, 126.5, 125.5, 125.3 , 125.0, 124.3, 122.6, 122.3, 120.7, 109.7, 101.0, 60.4, 14.7; IR (ATR): 3047, 2973, 2897, 1667, 1492, 1452 cm < -1 & gt ;; HRMS (ESI) calcd for C 29 H 21 NO 2 [M + H] + 416.1645, found 416.1646.
실시예 29. 에틸 10-메톡시-5-페닐인돌로[2,1-a]이소퀴놀린-12-카복실레이트의 합성Example 29. Synthesis of ethyl 10-methoxy-5-phenylindolo [2,1-a] isoquinoline-12-carboxylate
수율 56%, 연노란색 고체Yield 56%, pale yellow solid
M.p. = 153-155 ℃; 1H NMR (300 MHz, CDCl3) δ 9.84 (d, J = 8.0 Hz, 1H), 8.08 (s, 1H), 7.84 (s, 1H), 7.73-7.42 (m, 9H), 7.00 (d, J = 8.1 Hz, 1H), 4.65-4.47 (q, J = 6.0 Hz, 2H), 3.93 (s, 3H), 1.58 (t, J = 6.8 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 166.4, 157.2, 137.5, 136.5, 130.7, 130.2, 129.6, 128.9, 128.8, 128.6, 128.0, 127.2, 125.9, 125.3, 125.1, 125.0, 120.4, 112.6, 110.4, 103.5, 100.4, 60.1, 55.4, 14.6; IR (ATR): 3047, 2967, 1680, 1612, 1490, 1450 1351 cm-1; HRMS (ESI) calcd for C26H21NO3 [M + H]+ 396.1594, found 396.1595.Mp = 153-155 [deg.] C; 1 H NMR (300 MHz, CDCl 3) δ 9.84 (d, J = 8.0 Hz, 1H), 8.08 (s, 1H), 7.84 (s, 1H), 7.73-7.42 (m, 9H), 7.00 (d, J = 8.1 Hz, 1H), 4.65-4.47 (q, J = 6.0 Hz, 2H), 3.93 (s, 3H), 1.58 (t, J = 6.8 Hz, 3H); 13 C NMR (75 MHz, CDCl 3) δ 166.4, 157.2, 137.5, 136.5, 130.7, 130.2, 129.6, 128.9, 128.8, 128.6, 128.0, 127.2, 125.9, 125.3, 125.1, 125.0, 120.4, 112.6, 110.4, 103.5 , 100.4, 60.1, 55.4, 14.6; IR (ATR): 3047, 2967, 1680, 1612, 1490, 1450, 1351 cm < -1 & gt ;; HRMS (ESI) calcd for C 26 H 21 NO 3 [M + H] + 396.1594, found 396.1595.
실시예 30. 에틸 5-페닐-10-(트리플루오로메틸)인돌로[2,1-a]이소퀴놀린-12-카복실레이트의 합성Example 30. Synthesis of ethyl 5-phenyl-10- (trifluoromethyl) indolo [2,1-a] isoquinoline-12-carboxylate
수율 62%, 연노란색 고체Yield 62%, pale yellow solid
M.p. = 169-170 ℃; 1H NMR (300 MHz, CDCl3) δ 9.86 (d, J = 8.1 Hz, 1H), 8.69 (s, 1H), 8.13 (s, 1H), 7.85 (d, J = 8.6 Hz, 1H), 7.76-7.38 (m, 9H), 4.57 (q, J = 14.1, 7.0 Hz, 2H), 1.58 (t, J = 7.0 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 165.8, 138.6, 136.1, 131.9, 131.1, 130.1, 129.8, 129.2, 128.8, 128.3, 127.9, 127.7, 126.4 (q, JF -C = 34.5 Hz), 126.0, 125.7, 125.0, 124.9 (q, JF -C = 270.75 Hz), 120.4 (q, JF -C = 4.5 Hz), 120.1, 118.7 (q, JF -C = 3.75 Hz), 110.2, 101.4, 60.6, 14.5; ; IR (ATR): 3073, 3024, 2983, 1682, 1582, 1502, 1492, 1452, 1325 cm-1; HRMS (ESI) calcd for C26H18F3NO2 [M + H]+ 434.1362, found 434.1368.Mp = 169-170 < 0 >C; 1 H NMR (300 MHz, CDCl 3) δ 9.86 (d, J = 8.1 Hz, 1H), 8.69 (s, 1H), 8.13 (s, 1H), 7.85 (d, J = 8.6 Hz, 1H), 7.76 -7.38 (m, 9H), 4.57 (q, J = 14.1, 7.0 Hz, 2H), 1.58 (t, J = 7.0 Hz, 3H); 13 C NMR (75 MHz, CDCl 3) δ 165.8, 138.6, 136.1, 131.9, 131.1, 130.1, 129.8, 129.2, 128.8, 128.3, 127.9, 127.7, 126.4 (q, J F -C = 34.5 Hz), 126.0, 125.7, 125.0, 124.9 (q, J F -C = 270.75 Hz), 120.4 (q, J F -C = 4.5 Hz), 120.1, 118.7 (q, J F -C = 3.75 Hz), 110.2, 101.4, 60.6 , 14.5; ; IR (ATR): 3073, 3024, 2983, 1682, 1582, 1502, 1492, 1452, 1325 cm -1 ; HRMS (ESI) calcd for C 26 H 18 F 3 NO 2 [M + H] + 434.1362, found 434.1368.
실시예 31. 에틸 3-메톡시-5-페닐인돌로[2,1-a]이소퀴놀린-12-카복실레이트의 합성Example 31. Synthesis of ethyl 3-methoxy-5-phenylindolo [2,1-a] isoquinoline-12-carboxylate
수율 58%, 연노란색 고체Yield 58%, pale yellow solid
M.p. = 140-142 ℃; 1H NMR (300 MHz, CDCl3) δ 9.93 (d, J = 9.2 Hz, 1H), 8.38 (d, J = 8.1 Hz, 1H), 8.12 (s, 1H), 7.76 (d, J = 8.2 Hz, 1H), 7.61-7.39 (m, 6H), 7.34 (t, J = 7.4 Hz, 1H), 7.22 (d, J = 9.2 Hz, 1H), 7.10 (s, 1H), 4.56 (q, J = 7.1 Hz, 2H), 3.80 (s, 3H), 1.58 (t, J = 7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 166.6, 160.0, 138.0, 136.6, 133.3, 131.2, 130.8, 130.1, 128.8, 128.7, 128.1, 124.7, 124.2, 122.5, 121.8, 120.9, 119.1, 115.2, 109.4, 108.1, 99.4, 60.2, 55.3, 14.7; IR (ATR): 3096, 3000, 2970, 1699, 1606, 1465, 1354 cm-1; HRMS (ESI) calcd for C26H21NO3 [M + H]+ 396.1594, found 396.1591.Mp = 140-142 占 폚; 1 H NMR (300 MHz, CDCl 3) δ 9.93 (d, J = 9.2 Hz, 1H), 8.38 (d, J = 8.1 Hz, 1H), 8.12 (s, 1H), 7.76 (d, J = 8.2 Hz , 1H), 7.61-7.39 (m, 6H), 7.34 (t, J = 7.4 Hz, 1H), 7.22 (d, J = 9.2 Hz, 1H), 7.10 (s, 1H), 4.56 (q, J = 7.1 Hz, 2H), 3.80 (s, 3H), 1.58 (t, J = 7.1 Hz, 3H); 13 C NMR (75 MHz, CDCl 3 )? 166.6, 160.0, 138.0, 136.6, 133.3, 131.2, 130.8, 130.1, 128.8, 128.7, 128.1, 124.7, 124.2, 122.5, 121.8, 120.9, 119.1, 115.2, 109.4, 108.1 , ≪ / RTI > 99.4, 60.2, 55.3, 14.7; IR (ATR): 3096, 3000, 2970, 1699, 1606, 1465, 1354 cm -1 ; HRMS (ESI) calcd for C 26 H 21 NO 3 [M + H] + 396.1594, found 396.1591.
실시예 32. 에틸 3-브로모-5-페닐인돌로[2,1-a]이소퀴놀린-12-카복실레이트의 합성Example 32. Synthesis of ethyl 3-bromo-5-phenylindolo [2,1-a] isoquinoline-12-carboxylate
수율 27%, 연노란색 고체Yield 27%, pale yellow solid
M.p. = 215-218 ℃; 1H NMR (300 MHz, CDCl3) δ 9.81 (d, J = 9.0 Hz, 1H), 8.38 (d, J = 8.1 Hz, 1H), 8.15 (s, 1H), 7.78 (d, J = 8.7 Hz, 2H), 7.69 (dd, J = 9.0, 1.6 Hz, 1H), 7.52 (tt, J = 15.0, 7.3 Hz, 6H), 7.39 (t, J = 7.5 Hz, 1H), 4.56 (q, J = 7.1 Hz, 2H), 1.57 (t, J = 7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 166.4, 136.6, 135.8, 132.7, 130.8, 130.7, 130.4, 130.1, 128.9, 128.5, 128.4, 127.8, 124.5, 124.1, 124.0, 123.8, 122.7, 122.6, 121.5, 109.6, 101.3, 60.7, 14.6; IR (ATR): 3053, 2983, 1689, 1577, 1557, 1440 cm-1; HRMS (ESI) calcd for C25H18BrNO2 [M + H]+ 444.0594, found 444.0598.Mp = 215-218 [deg.] C; 1 H NMR (300 MHz, CDCl 3) δ 9.81 (d, J = 9.0 Hz, 1H), 8.38 (d, J = 8.1 Hz, 1H), 8.15 (s, 1H), 7.78 (d, J = 8.7 Hz , 2H), 7.69 (dd, J = 9.0, 1.6 Hz, 1H), 7.52 (tt, J = 15.0, 7.3 Hz, 6H), 7.39 (t, J = 7.5 Hz, 1H), 4.56 (q, J = 7.1 Hz, 2H), 1.57 (t, J = 7.1 Hz, 3H); 13 C NMR (75 MHz, CDCl 3) δ 166.4, 136.6, 135.8, 132.7, 130.8, 130.7, 130.4, 130.1, 128.9, 128.5, 128.4, 127.8, 124.5, 124.1, 124.0, 123.8, 122.7, 122.6, 121.5, 109.6 , 101.3, 60.7, 14.6; IR (ATR): 3053, 2983, 1689, 1577, 1557, 1440 cm < -1 & gt ;; HRMS (ESI) calcd for C 25 H 18 BrNO 2 [M + H] + 444.0594, found 444.0598.
시험예 1.분자내 동적 동위원소 효과(kinetic isotope effect, KIE) 평가Test Example 1. Kinetic isotope effect (KIE) evaluation
반응 메카니즘을 확인하기 위하여 실시예 1 및 실시예 17의 화합물을 제조하여 분자내 동적 동위원소효과를 평가하였다.To confirm the reaction mechanism, the compounds of Example 1 and Example 17 were prepared to evaluate the intramolecular dynamic isotopic effect.
실시예 1의 화합물은 팔라듐 촉매하의 5-exo-dig 고리화에서 CH 활성화반응을 통해 진행된다는 것을 확인할 수 있을 정도로 충분한 수소/중수소간 KIE(K H/K D=2.86)가 나타났다. 강한 KIE와 Z-이성질체의 형성에 기초해서, 삼중결합에 대한 시스-마이그래토리 삽입에 의한 알카인 다이렉트 오쏘-팔라데이션과 프로토디팔라데이션이 실시예 1의 화합물을 형성하는 것으로 예측된다. There was sufficient hydrogen / deuterium KIE ( K H / K D = 2.86) to confirm that the compound of Example 1 proceeded via CH activation in the 5-exo-dig cyclization under palladium catalyst. Based on the formation of strong KIE and Z-isomers, it is expected that alkane direct ortho-palladium and protopyridylation by cis-migrator insertion into the triple bond will form the compound of Example 1.
반면, 백금 촉매하에서는 6-endo-dig 고리화에서는 KIE(K H/K D=0.50)가 나타났고, 이것은 친전자성 방향족 치환반응의 메카니즘과 일치한다. 이러한 사실은 백금 촉매로 활성된 알키닐 유닛상의 이웃하는 방향족 고리에 의한 분자 내공격을 포함하는 6-endo-dig 고리화를 위한 친전자성 경로와 이어진 프로토디메탈레이션 과정을 거쳐서 실시예 17의 화합물이 형성되는 것이 뒷받침되었다.On the other hand, KIE ( K H / K D = 0.50) appeared on the 6-endo-dig cyclization under platinum catalyst, which is consistent with the mechanism of the electrophilic aromatic substitution reaction. This fact was confirmed by the protodymetallation process coupled with the electrophilic route for 6-endo-dig cyclization involving an intramolecular attack by a neighboring aromatic ring on the platinum catalyzed alkynyl unit, Lt; / RTI >
Claims (11)
[화학식 1]
식 중에서,
는 단일 또는 이중결합이고,
A는 질소 원자를 포함하는, 5-6원 헤테로시클릭 또는 5-6원 헤테로아릴이고,
R1은 수소, 직쇄형 또는 분지형 C1 - 6알킬 및 CO2Ra 중에서 선택되고,
R2, R3, R4, R5 및 R6은 서로 동일하거나 또는 상이하고, 각각 독립적으로 수소, 할로, 직쇄형 또는 분지형 C1 - 6알킬, CO2Ra, C1 - 6알킬옥시, 트리할로메틸, 페닐 및 벤질 중에서 선택되고,
R7은 직쇄형 또는 분지형 C1 - 6알킬, C3 - 7시클로알킬, 아릴, 헤테로아릴, 아릴C1-6알킬 및 헤테로아릴C1 - 6알킬 중에서 선택되고; 상기 아릴 또는 아릴C1 - 6알킬의 아릴은 페닐 또는 나프틸이며; 상기 헤테로아릴 또는 헤테로아릴C1 - 6알킬의 헤테로아릴은 N, O 및 S 중에서 선택되는 1 내지 2개의 이종원자를 가지는 5-6원 헤테로아릴, 1H-인돌릴 또는 1H-퀴놀리닐이며; 상기 아릴, 헤테로아릴, 아릴C1 - 6알킬 및 헤테로아릴C1- 6알킬은 각각 독립적으로 비치환되거나 또는 할로, 직쇄형 또는 분지형 C1-6알킬, C1 - 6알킬옥시, 트리할로메틸, -COOH, -CHO, -COORb, 페닐 및 벤질 중에서 선택되는 1 내지 3개의 치환기로 치환될 수 있고,
Ra 및 Rb는 서로 동일하거나 또는 상이하고, 각각 독립적으로 직쇄형 또는 분지형 C1 - 6알킬이다.A compound represented by the following formula (1):
[Chemical Formula 1]
In the formula,
Is a single or double bond,
A is a 5-6 membered heterocyclic or 5-6 membered heteroaryl containing a nitrogen atom,
R 1 is hydrogen, straight or branched C 1 - 6 alkyl and is selected from CO 2 R a,
R 2, R 3, R 4 , R 5 and R 6 are the same or different and each is independently hydrogen, halo, straight or branched C 1 to each other - 6 alkyl, CO 2 R a, C 1 - 6 alkyl Oxy, trihalomethyl, phenyl and benzyl,
R 7 is straight or branched C 1 - 6 alkyl is selected from 6-alkyl, C 3 - - 7 cycloalkyl, aryl, heteroaryl, aryl C 1-6 alkyl and heteroaryl C 1; And the aryl or aryl C 1 - 6 alkyl, aryl is phenyl or naphthyl; Wherein the heteroaryl or heteroaryl C 1 - 6 alkyl heteroaryl is N, O, and 5-6 membered having from 1 to 2 heteroatoms selected from S-heteroaryl, 1H- indolyl or quinolinyl 1H- and; Wherein the aryl, heteroaryl, aryl C 1 - 6 alkyl and heteroaryl C 1- 6 alkyl, each independently unsubstituted or substituted by halo, straight or branched C 1-6 alkyl, C 1 - 6 alkyloxy, trihalomethyl Romero naphthyl, may be optionally substituted by -COOH, -CHO, -COOR b, phenyl, and 1 to 3 substituents selected from benzyl,
R a and R b are the same or different and each is independently a straight or branched C 1 to each other - a 6 alkyl.
하기 화학식 2 또는 화학식 3으로 표시되는 것인, 화합물:
[화학식 2]
[화학식 3]
식 중에서,
R1은 수소, 직쇄형 또는 분지형 C1 - 6알킬 및 CO2Ra 중에서 선택되고,
R2, R3, R4, R5 및 R6은 서로 동일하거나 또는 상이하고, 각각 독립적으로 수소, 할로, 직쇄형 또는 분지형 C1 - 6알킬, CO2Ra, C1 - 6알킬옥시, 트리할로메틸, 페닐 및 벤질 중에서 선택되고,
R8은 직쇄형 또는 분지형 C1 - 6알킬, C3 - 7시클로알킬, 아릴 및 헤테로아릴 중에서 선택되고, 상기 아릴은 페닐 또는 나프틸이며; 상기 헤테로아릴은 N, O 및 S 중에서 선택되는 1 내지 2개의 이종원자를 가지는 5-6원 헤테로아릴, 1H-인돌릴 또는 1H-퀴놀리닐이고, 상기 아릴 및 헤테로아릴은 각각 독립적으로 비치환되거나 또는 할로, 직쇄형 또는 분지형 C1 - 6알킬, C1 - 6알킬옥시, 트리할로메틸, -COOH, -CHO, -COORb, 페닐 및 벤질 중에서 선택되는 1 내지 3개의 치환기로 치환될 수 있고,
Ra 및 Rb는 서로 동일하거나 또는 상이하고, 각각 독립적으로 직쇄형 또는 분지형 C1 - 6알킬이다.The method according to claim 1,
A compound represented by the following formula (2) or (3):
(2)
(3)
In the formula,
R 1 is hydrogen, straight or branched C 1 - 6 alkyl and is selected from CO 2 R a,
R 2, R 3, R 4 , R 5 and R 6 are the same or different and each is independently hydrogen, halo, straight or branched C 1 to each other - 6 alkyl, CO 2 R a, C 1 - 6 alkyl Oxy, trihalomethyl, phenyl and benzyl,
R 8 is straight or branched C 1 - 6 alkyl, C 3 - 7 is selected from cycloalkyl, aryl, and heteroaryl, wherein the aryl is phenyl or naphthyl; Wherein said heteroaryl is 5-6 membered heteroaryl, 1H-indolyl or lH-quinolinyl having 1-2 heteroatoms selected from N, O and S, said aryl and heteroaryl being each independently unsubstituted or substituted or halo, straight or branched C 1 - 6 alkyl, C 1 - 6 alkyl optionally substituted by oxy, methyl, -COOH, -CHO, -COOR b, phenyl and benzyl 1 to 3 substituents selected from trihaloalkyl Can,
R a and R b are the same or different and each is independently a straight or branched C 1 to each other - a 6 alkyl.
R1은 CO2Et인, 화합물.The method according to claim 1,
R 1 is CO 2 Et Compounds.
R1은 CO2Et이고,
R8은 직쇄형 또는 분지형 C1 - 6알킬, 아릴 및 헤테로아릴 중에서 선택되고, 상기 아릴은 페닐 또는 나프틸이며; 상기 헤테로아릴은 O 및 S 중에서 선택되는 1 내지 2개의 이종원자를 가지는 5-6원 헤테로아릴이고; 상기 아릴 및 헤테로아릴은 각각 독립적으로 비치환되거나 또는 할로, 직쇄형 또는 분지형 C1 - 6알킬, C1 - 6알킬옥시, 트리할로메틸, -COOH, -CHO 및 -COORb 중에서 선택되는 1 내지 3개의 치환기로 치환될 수 있고,
Rb는 직쇄형 또는 분지형 C1 - 6알킬인, 화합물.3. The method of claim 2,
R 1 is CO 2 Et,
R 8 is straight or branched C 1 - 6 is selected from alkyl, aryl and heteroaryl, wherein the aryl is phenyl or naphthyl; Wherein said heteroaryl is 5-6 membered heteroaryl having 1 to 2 heteroatoms selected from O and S; Wherein aryl and heteroaryl are each independently unsubstituted or substituted by halo, straight or branched C 1 - 6 is alkyloxy, selected from methyl, -COOH, -CHO and -COOR b trihaloalkyl - 6 alkyl, C 1 Which may be substituted with 1 to 3 substituents,
R b is a straight or branched C 1 - 6 alkyl, compound.
에틸 (Z)-6-벤질리덴-6H-이소인돌로[2,1-a]인돌-11-카복실레이트;
에틸 (Z)-6-(4-메틸벤질리덴)-6H-이소인돌로[2,1-a]인돌-11-카복실레이트;
에틸 (Z)-6-(4-(메톡시카보닐)벤질리덴)-6H-이소인돌로[2,1-a]인돌-11-카복실레이트;
에틸 (Z)-6-(4-포밀벤질리덴)-6H-이소인돌로[2,1-a]인돌-11-카복실레이트;
에틸 (Z)-6-(4-(트리플루오로메틸)벤질리덴)-6H-이소인돌로[2,1-a]인돌-11-카복실레이트;
에틸 (Z)-6-(4-플루오로벤질리덴)-6H-이소인돌로[2,1-a]인돌-11-카복실레이트;
에틸 (Z)-6-(2-메틸벤질리덴)-6H-이소인돌로[2,1-a]인돌-11-카복실레이트;
에틸 (Z)-6-(3-메톡시벤질리덴)-6H-이소인돌로[2,1-a]인돌-11-카복실레이트;
에틸 (Z)-6-(3-클로로벤질리덴)-6H-이소인돌로[2,1-a]인돌-11-카복실레이트;
에틸 (Z)-6-(3-클로로벤질리덴)-6H-이소인돌로[2,1-a]인돌-11-카복실레이트;
에틸 (Z)-6-(티오펜-2-일메틸렌)-6H-이소인돌로[2,1-a]인돌-11-카복실레이트;
에틸 (Z)-6-(나프탈렌-2-일메틸렌)-6H-이소인돌로[2,1-a]인돌-11-카복실레이트;
에틸 (Z)-6-벤질리덴-2-메톡시-6H-이소인돌로[2,1-a]인돌-11-카복실레이트;
에틸 (Z)-6-벤질리덴-2-(트리플루오로메틸)-6H-이소인돌로[2,1-a]인돌-11-카복실레이트;
에틸 (Z)-6-벤질리덴-8-메톡시-6H-이소인돌로[2,1-a]인돌-11-카복실레이트;
에틸 (Z)-6-벤질리덴-8-브로모-6H-이소인돌로[2,1-a]인돌-11-카복실레이트;
에틸 5-페닐인돌로[2,1-a]이소퀴놀린-12-카복실레이트;
에틸 5-(p-톨릴)인돌로[2,1-a]이소퀴놀린-12-카복실레이트;
에틸 5-(4-(메톡시카보닐)페닐)인돌로[2,1-a]이소퀴놀린-12-카복실레이트;
에틸 5-(4-포밀페닐)인돌로[2,1-a]이소퀴놀린-12-카복실레이트;
에틸 5-(4-(트리플루오로메틸)페닐)인돌로[2,1-a]이소퀴놀린-12-카복실레이트;
에틸 5-(4-플루오로페닐)인돌로[2,1-a]이소퀴놀린-12-카복실레이트;
에틸 5-(o-톨릴)인돌로[2,1-a]이소퀴놀린-12-카복실레이트;
에틸 5-(3-메톡시페닐)인돌로[2,1-a]이소퀴놀린-12-카복실레이트;
에틸 5-(3-클로로페닐)인돌로[2,1-a]이소퀴놀린-12-카복실레이트;
에틸 5-헥실인돌로[2,1-a]이소퀴놀린-12-카복실레이트;
에틸 5-(티오펜-2-yl)인돌로[2,1-a]이소퀴놀린-12-카복실레이트;
에틸 5-(나프탈렌-2-일)인돌로[2,1-a]이소퀴놀린-12-카복실레이트;
에틸 10-메톡시-5-페닐인돌로[2,1-a]이소퀴놀린-12-카복실레이트;
에틸 5-페닐-10-(트리플루오로메틸)인돌로[2,1-a]이소퀴놀린-12-카복실레이트;
에틸 3-메톡시-5-페닐인돌로[2,1-a]이소퀴놀린-12-카복실레이트; 및
에틸 3-브로모-5-페닐인돌로[2,1-a]이소퀴놀린-12-카복실레이트;로 이루어진 군 중에서 선택되는 것인, 화합물.The method according to claim 1,
Ethyl (Z) -6-benzylidene-6H-isoindolo [2,1-a] indole-11-carboxylate;
Ethyl (Z) -6- (4-methylbenzylidene) -6H-isoindolo [2,1-a] indole-11-carboxylate;
Ethyl (Z) -6- (4- (methoxycarbonyl) benzylidene) -6H-isoindolo [2,1-a] indole-11-carboxylate;
Ethyl (Z) -6- (4-formylbenzylidene) -6H-isoindolo [2,1-a] indole-11-carboxylate;
Ethyl (Z) -6- (4- (trifluoromethyl) benzylidene) -6H-isoindolo [2,1-a] indole-11-carboxylate;
Ethyl (Z) -6- (4-fluorobenzylidene) -6H-isoindolo [2,1-a] indole-11-carboxylate;
Ethyl (Z) -6- (2-methylbenzylidene) -6H-isoindolo [2,1-a] indole-11-carboxylate;
Ethyl (Z) -6- (3-methoxybenzylidene) -6H-isoindolo [2,1-a] indole-11-carboxylate;
Ethyl (Z) -6- (3-chlorobenzylidene) -6H-isoindolo [2,1-a] indole-11-carboxylate;
Ethyl (Z) -6- (3-chlorobenzylidene) -6H-isoindolo [2,1-a] indole-11-carboxylate;
Ethyl (Z) -6- (thiophen-2-ylmethylene) -6H-isoindolo [2,1-a] indole-11-carboxylate;
Ethyl (Z) -6- (naphthalene-2-ylmethylene) -6H-isoindolo [2,1-a] indole-11-carboxylate;
Ethyl (Z) -6-benzylidene-2-methoxy-6H-isoindolo [2,1-a] indole-11-carboxylate;
Ethyl (Z) -6-benzylidene-2- (trifluoromethyl) -6H-isoindolo [2,1-a] indole-11-carboxylate;
Ethyl (Z) -6-benzylidene-8-methoxy-6H-isoindolo [2,1-a] indole-11-carboxylate;
Ethyl (Z) -6-benzylidene-8-bromo-6H-isoindolo [2,1-a] indole-11-carboxylate;
Ethyl 5-phenylindolo [2,1-a] isoquinoline-12-carboxylate;
Ethyl 5- (p-tolyl) indolo [2,1-a] isoquinoline-12-carboxylate;
Ethyl 5- (4- (methoxycarbonyl) phenyl) indolo [2,1-a] isoquinoline-12-carboxylate;
Ethyl 5- (4-formylphenyl) indolo [2,1-a] isoquinoline-12-carboxylate;
Ethyl 5- (4- (trifluoromethyl) phenyl) indolo [2,1-a] isoquinoline-12-carboxylate;
Ethyl 5- (4-fluorophenyl) indolo [2,1-a] isoquinoline-12-carboxylate;
Ethyl 5- (o-tolyl) indolo [2,1-a] isoquinoline-12-carboxylate;
Ethyl 5- (3-methoxyphenyl) indolo [2,1-a] isoquinoline-12-carboxylate;
Ethyl 5- (3-chlorophenyl) indolo [2,1-a] isoquinoline-12-carboxylate;
Ethyl 5-hexylindolo [2,1-a] isoquinoline-12-carboxylate;
Ethyl 5- (thiophen-2-yl) indolo [2,1-a] isoquinoline-12-carboxylate;
Ethyl 5- (naphthalen-2-yl) indolo [2,1-a] isoquinoline-12-carboxylate;
Ethyl 10-methoxy-5-phenylindolo [2,1-a] isoquinoline-12-carboxylate;
Ethyl 5-phenyl-10- (trifluoromethyl) indolo [2,1-a] isoquinoline-12-carboxylate;
Ethyl 3-methoxy-5-phenylindolo [2,1-a] isoquinoline-12-carboxylate; And
Ethyl 3-bromo-5-phenylindolo [2,1-a] isoquinoline-12-carboxylate.
[화학식 3]
[화학식 1]
식 중에서,
는 단일 또는 이중결합이고,
A는 질소 원자를 포함하는, 5-6원 헤테로시클릭 또는 5-6원 헤테로아릴이고,
R1은 수소, 직쇄형 또는 분지형 C1 - 6알킬 및 CO2Ra 중에서 선택되고,
R2, R3, R4, R5 및 R6은 서로 동일하거나 또는 상이하고, 각각 독립적으로 수소, 할로, 직쇄형 또는 분지형 C1 - 6알킬, CO2Ra, C1 - 6알킬옥시, 트리할로메틸, 페닐 및 벤질 중에서 선택되고,
R7은 직쇄형 또는 분지형 C1 - 6알킬, C3 - 7시클로알킬, 아릴, 헤테로아릴, 아릴C1-6알킬 및 헤테로아릴C1 - 6알킬 중에서 선택되고; 상기 아릴 또는 아릴C1 - 6알킬의 아릴은 페닐 또는 나프틸이며; 상기 헤테로아릴 또는 헤테로아릴C1 - 6알킬의 헤테로아릴은 N, O 및 S 중에서 선택되는 1 내지 2개의 이종원자를 가지는 5-6원 헤테로아릴, 1H-인돌릴 또는 1H-퀴놀리닐이며; 상기 아릴, 헤테로아릴, 아릴C1 - 6알킬 및 헤테로아릴C1- 6알킬은 각각 독립적으로 비치환되거나 또는 할로, 직쇄형 또는 분지형 C1-6알킬, C1 - 6알킬옥시, 트리할로메틸, -COOH, -CHO, -COORb, 페닐 및 벤질 중에서 선택되는 1 내지 3개의 치환기로 치환될 수 있고,
Ra 및 Rb는 서로 동일하거나 또는 상이하고, 각각 독립적으로 직쇄형 또는 분지형 C1 - 6알킬이다.A process for producing a compound represented by the following formula (1), which comprises refluxing a compound of the following formula (3) under a transition metal catalyst to form an intramolecular ring bond:
(3)
[Chemical Formula 1]
In the formula,
Is a single or double bond,
A is a 5-6 membered heterocyclic or 5-6 membered heteroaryl containing a nitrogen atom,
R 1 is hydrogen, straight or branched C 1 - 6 alkyl and is selected from CO 2 R a,
R 2, R 3, R 4 , R 5 and R 6 are the same or different and each is independently hydrogen, halo, straight or branched C 1 to each other - 6 alkyl, CO 2 R a, C 1 - 6 alkyl Oxy, trihalomethyl, phenyl and benzyl,
R 7 is straight or branched C 1 - 6 alkyl is selected from 6-alkyl, C 3 - - 7 cycloalkyl, aryl, heteroaryl, aryl C 1-6 alkyl and heteroaryl C 1; And the aryl or aryl C 1 - 6 alkyl, aryl is phenyl or naphthyl; Wherein the heteroaryl or heteroaryl C 1 - 6 alkyl heteroaryl is N, O, and 5-6 membered having from 1 to 2 heteroatoms selected from S-heteroaryl, 1H- indolyl or quinolinyl 1H- and; Wherein the aryl, heteroaryl, aryl C 1 - 6 alkyl and heteroaryl C 1- 6 alkyl, each independently unsubstituted or substituted by halo, straight or branched C 1-6 alkyl, C 1 - 6 alkyloxy, trihalomethyl Romero naphthyl, may be optionally substituted by -COOH, -CHO, -COOR b, phenyl, and 1 to 3 substituents selected from benzyl,
R a and R b are the same or different and each is independently a straight or branched C 1 to each other - a 6 alkyl.
상기 전이금속 촉매는 Pd(OAc)2, PtCl4 및 AuCl3 중에서 선택되는 것인, 제조방법.The method according to claim 6,
Wherein the transition metal catalyst is selected from Pd (OAc) 2 , PtCl 4 and AuCl 3 .
상기 전이금속 촉매가 Pd(OAc)2이면, α-첨가반응(5-exo-dig 고리화)이 형성되어 하기 화학식 2로 표시되는 화합물이 형성되는 것인, 제조방법:
[화학식 2]
식 중에서,
R1은 수소, 직쇄형 또는 분지형 C1 - 6알킬 및 CO2Ra 중에서 선택되고,
R2, R3, R4, R5 및 R6은 서로 동일하거나 또는 상이하고, 각각 독립적으로 수소, 할로, 직쇄형 또는 분지형 C1 - 6알킬, CO2Ra, C1 - 6알킬옥시, 트리할로메틸, 페닐 및 벤질 중에서 선택되고,
R8은 직쇄형 또는 분지형 C1 - 6알킬, C3 - 7시클로알킬, 아릴 및 헤테로아릴 중에서 선택되고, 상기 아릴은 페닐 또는 나프틸이며; 상기 헤테로아릴은 N, O 및 S 중에서 선택되는 1 내지 2개의 이종원자를 가지는 5-6원 헤테로아릴, 1H-인돌릴 또는 1H-퀴놀리닐이고, 상기 아릴 및 헤테로아릴은 각각 독립적으로 비치환되거나 또는 할로, 직쇄형 또는 분지형 C1 - 6알킬, C1 - 6알킬옥시, 트리할로메틸, -COOH, -CHO, -COORb, 페닐 및 벤질 중에서 선택되는 1 내지 3개의 치환기로 치환될 수 있고,
Ra 및 Rb는 서로 동일하거나 또는 상이하고, 각각 독립적으로 직쇄형 또는 분지형 C1 - 6알킬이다.8. The method of claim 7,
(5-exo-dig cyclization) is formed when the transition metal catalyst is Pd (OAc) 2 , thereby forming a compound represented by the following general formula (2): ????????
(2)
In the formula,
R 1 is hydrogen, straight or branched C 1 - 6 alkyl and is selected from CO 2 R a,
R 2, R 3, R 4 , R 5 and R 6 are the same or different and each is independently hydrogen, halo, straight or branched C 1 to each other - 6 alkyl, CO 2 R a, C 1 - 6 alkyl Oxy, trihalomethyl, phenyl and benzyl,
R 8 is straight or branched C 1 - 6 alkyl, C 3 - 7 is selected from cycloalkyl, aryl, and heteroaryl, wherein the aryl is phenyl or naphthyl; Wherein said heteroaryl is 5-6 membered heteroaryl, 1H-indolyl or lH-quinolinyl having 1-2 heteroatoms selected from N, O and S, said aryl and heteroaryl being each independently unsubstituted or substituted or halo, straight or branched C 1 - 6 alkyl, C 1 - 6 alkyl optionally substituted by oxy, methyl, -COOH, -CHO, -COOR b, phenyl and benzyl 1 to 3 substituents selected from trihaloalkyl Can,
R a and R b are the same or different and each is independently a straight or branched C 1 to each other - a 6 alkyl.
상기 전이금속 촉매가 Pd(OAc)2이면, 반응시 리간드로서 PPh3를 더 포함하는 것인, 제조방법.8. The method of claim 7,
Wherein when the transition metal catalyst is Pd (OAc) 2, it further comprises PPh 3 as a ligand during the reaction.
상기 전이금속 촉매가 PtCl4 또는 AuCl3이면, β-첨가반응(6-endo-dig 고리화)이 형성되어 하기 화학식 3으로 표시되는 화합물이 형성되는 것인, 제조방법:
[화학식 3]
식 중에서,
R1은 수소, 직쇄형 또는 분지형 C1 - 6알킬 및 CO2Ra 중에서 선택되고,
R2, R3, R4, R5 및 R6은 서로 동일하거나 또는 상이하고, 각각 독립적으로 수소, 할로, 직쇄형 또는 분지형 C1 - 6알킬, CO2Ra, C1 - 6알킬옥시, 트리할로메틸, 페닐 및 벤질 중에서 선택되고,
R8은 직쇄형 또는 분지형 C1 - 6알킬, C3 - 7시클로알킬, 아릴 및 헤테로아릴 중에서 선택되고, 상기 아릴은 페닐 또는 나프틸이며; 상기 헤테로아릴은 N, O 및 S 중에서 선택되는 1 내지 2개의 이종원자를 가지는 5-6원 헤테로아릴, 1H-인돌릴 또는 1H-퀴놀리닐이고, 상기 아릴 및 헤테로아릴은 각각 독립적으로 비치환되거나 또는 할로, 직쇄형 또는 분지형 C1 - 6알킬, C1 - 6알킬옥시, 트리할로메틸, -COOH, -CHO, -COORb, 페닐 및 벤질 중에서 선택되는 1 내지 3개의 치환기로 치환될 수 있고,
Ra 및 Rb는 서로 동일하거나 또는 상이하고, 각각 독립적으로 직쇄형 또는 분지형 C1 - 6알킬이다.8. The method of claim 7,
Wherein the transition metal catalyst is PtCl 4 or AuCl 3 , a β-addition reaction (6-endo-dig cyclization) is formed to form a compound represented by the following formula (3)
(3)
In the formula,
R 1 is hydrogen, straight or branched C 1 - 6 alkyl and is selected from CO 2 R a,
R 2, R 3, R 4 , R 5 and R 6 are the same or different and each is independently hydrogen, halo, straight or branched C 1 to each other - 6 alkyl, CO 2 R a, C 1 - 6 alkyl Oxy, trihalomethyl, phenyl and benzyl,
R 8 is straight or branched C 1 - 6 alkyl, C 3 - 7 is selected from cycloalkyl, aryl, and heteroaryl, wherein the aryl is phenyl or naphthyl; Wherein said heteroaryl is 5-6 membered heteroaryl, 1H-indolyl or lH-quinolinyl having 1-2 heteroatoms selected from N, O and S, said aryl and heteroaryl being each independently unsubstituted or substituted or halo, straight or branched C 1 - 6 alkyl, C 1 - 6 alkyl optionally substituted by oxy, methyl, -COOH, -CHO, -COOR b, phenyl and benzyl 1 to 3 substituents selected from trihaloalkyl Can,
R a and R b are the same or different and each is independently a straight or branched C 1 to each other - a 6 alkyl.
상기 전이금속 촉매는 2 내지 20 mol%로 첨가되는 것인, 제조방법.The method according to claim 6,
Wherein the transition metal catalyst is added in an amount of 2 to 20 mol%.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170131542A KR102060527B1 (en) | 2017-10-11 | 2017-10-11 | 4 Ring-fused N-heterocycles having luminescent properties and Preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170131542A KR102060527B1 (en) | 2017-10-11 | 2017-10-11 | 4 Ring-fused N-heterocycles having luminescent properties and Preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20190040791A true KR20190040791A (en) | 2019-04-19 |
KR102060527B1 KR102060527B1 (en) | 2019-12-30 |
Family
ID=66283411
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020170131542A KR102060527B1 (en) | 2017-10-11 | 2017-10-11 | 4 Ring-fused N-heterocycles having luminescent properties and Preparation method thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102060527B1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113105460A (en) * | 2021-04-27 | 2021-07-13 | 扬州大学 | Synthesis method of 6-hydroisoindolo [2, 1-alpha ] indole compound |
KR20220165575A (en) * | 2021-06-08 | 2022-12-15 | 중앙대학교 산학협력단 | Isoindoloindolone derivatives and manufacturing method thereof |
-
2017
- 2017-10-11 KR KR1020170131542A patent/KR102060527B1/en active IP Right Grant
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113105460A (en) * | 2021-04-27 | 2021-07-13 | 扬州大学 | Synthesis method of 6-hydroisoindolo [2, 1-alpha ] indole compound |
CN113105460B (en) * | 2021-04-27 | 2022-10-25 | 扬州大学 | Synthesis method of 6-hydroisoindolo [2, 1-alpha ] indole compound |
KR20220165575A (en) * | 2021-06-08 | 2022-12-15 | 중앙대학교 산학협력단 | Isoindoloindolone derivatives and manufacturing method thereof |
Also Published As
Publication number | Publication date |
---|---|
KR102060527B1 (en) | 2019-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW201632497A (en) | 3-oxo-3-(arylamino)propanoates, a process for their preparation, and their use in preparing pyrrolidinones | |
CN107857773B (en) | The quinazolinone boride that 2- nitrogen heteroaromatic rings replace | |
KR20130142477A (en) | Method for preparation of nitrocyclopropane derivatives | |
JP6968067B2 (en) | Arylization method | |
KR102060527B1 (en) | 4 Ring-fused N-heterocycles having luminescent properties and Preparation method thereof | |
Gvozdev et al. | Selective one-pot synthesis of 11-arylmethylidene-11H-isoindolo-[2, 1-a] benzimidazoles and 6-arylbenzimidazo [2, 1-a] isoquinolines from o-alkynylbenzaldehydes and o-diaminobenzenes | |
JP6067228B2 (en) | Improved process for the preparation of etoroxixib intermediate, 1- (6-methylpyridin-3-yl) -2- [4- (methylsulfonyl) phenyl] ethanone | |
Carrer et al. | Synthesis of 3-aryl-2-arylamidobenzofurans based on the curtius rearrangement | |
Kumar et al. | Facile “on water” domino reactions for the expedient synthesis of 2 H-thiopyrano [2, 3-b] quinolines | |
US9487547B2 (en) | Cyclic phosphinate derivatives and method of preparing the same | |
KR101845935B1 (en) | preparation method of pyridoisoindole derivatives | |
JP2012176928A (en) | Pyrene derivative, production method of pyrene derivative, complex, catalyst, electronic material, light-emitting material and pigment | |
KR20030017473A (en) | One-pot synthesis of alkyl 3-cyclopropylamino-2-[2,4-dibromo-3-(difluoromethoxy)benzoyl]-2-propenoate as a useful intermediate for antibacterial quinolone medicaments | |
KR101856537B1 (en) | Synthetic method of tetrahydroisoquinoline derivatives | |
KR102060523B1 (en) | Multi-fused N-heterocycles having luminescent properties and Preparation method thereof | |
KR101540623B1 (en) | Novel preparation method of benzoxazole derivative | |
KR101840518B1 (en) | New Carbazoles and Preparation method thereof | |
Viradiya et al. | PEG mediated eco-friendly one pot sunthesis of benzylamine coumarin derivatives using multicomponent reactant | |
KR101815001B1 (en) | 4-Substituted-5-membered-ring-sulfamidate-5-phosphonate compounds and Method for the stereoselective preparation thereof | |
CN110183394B (en) | Method for preparing 3-cyanoethyl-2-alkyl-4H-benzoxazine from bromoacetonitrile under blue light irradiation condition | |
KR101345749B1 (en) | Method for the stereoselective preparation of 4,5-diaryl 5-membered ring sulfamidates | |
KR101938354B1 (en) | 3-(alkenyl)indolizine compounds and its preparation method | |
EP3098217B1 (en) | Method for producing optically active carboxylic acid ester | |
KR101742022B1 (en) | New Biaryl Compounds and Preparation method thereof by benzannulation | |
JP3918468B2 (en) | 3,3-bis (alkoxycarbonyl-methylthio) propionitrile and process for producing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |